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In response to health workforce shortages policymakers have considered expanding 
the roles that a health professional may perform.  A more traditional combination of 
health professional roles is that of a dispensing doctor (DD) who routinely prescribes 
and dispenses pharmaceuticals.  A systematic review conducted on mainly overseas 
DDs’ practices found that DDs tended to prescribe more items per patients, less often 
generically, and showed poorer adherence to best practice.  Convenience for patients 
was cited by both patients and DDs as the main reason for dispensing.  In Australia, 
rural doctors are allowed to dispense Pharmaceutical Benefit Scheme (PBS) 
subsidised pharmaceutical benefits if there is no reasonable pharmacy coverage.  






To examine the PBS prescribing patterns of dispensing with matched non-dispensing 






A sequential explanatory (QUANqual) mixed methodology was utilised.  Firstly, 
rurality-matched DDs’ and non-DDs’ PBS data for fiscal years 2005-7 were analysed 
against criteria distilled from a systematic review and stakeholder consultations.  
Secondly, structured interviews were conducted with a purposive sample of DDs to 






Key findings:  
 
DDs prescribed significantly fewer PBS prescriptions per patients but used 
Regulation 24 significantly more than non-DDs.  Regulation 24 biased the 
prescribing data.  DDs prescribed proportionally more penicillin type antibiotics, 
adrenergic inhalants and non-steroidal anti-inflammatories as compared to non-DDs.  
Reasons offered by DD-respondents highlighted that prescribing was influenced by 
an awareness of cost to the patients, peer pressure and confidential prescriber 






This innovative census study does not support international data that DDs are less 
judicious in their prescribing.  There is some evidence that DDs might reduce health 
inequity between rural and urban Australian, and that the DD health model is 
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A global health workforce shortage exists, and this crisis is expected to worsen 
(Australian Institute of Health and Welfare 1997; Duckett 2005a, 2006; World 
Health Organization 2006; Greenhill, Mildenhall, and Rosenthal 2008; National 
Rural Health Alliance 2008d; General Practice in Australia, Health Priorities and 
Policies 1998 to 2008  2009; Dunbar and Reddy 2009; Gregory 2009; Gorman and 
Brooks 2009; Wilson et al. 2009; Naccarella, Buchan, and Brooks 2010; O'Toole, 
Schoo, and Hernan 2010; O'Toole and Schoo 2010).  Some government policy-
makers have introduced strategies to attract more people into the healthcare 
professions as well as expanding the roles of existing health workers (Duckett 2005b; 
Duckett 2005a; Van Der Weyden 2005; Duckett 2006; Gupte 2007; Wakerman et al. 
2008; Duckett 2009; Wakerman 2009; Wakerman et al. 2009).  These have included 
the creation of: 
• nurse practitioners (Arnold 2004; Australian Medical Association 2005b; Van 
Der Weyden 2005; Hooker 2006; Hollinghurst et al. 2006; Dunn, Cashin, and 
Buckley 2008; Thistlethwaite and Topps 2009; Gorman and Brooks 2009; Daele 
et al. 2009; Eton 2009; Haikerwal 2009b; Parnell 2009; Naccarella, Buchan, and 
Brooks 2010; Nissen 2010); 
• physician assistants (Arnold 2004; Cipher, Hooker, and Sekscenski 2006; Hooker 
2006; Anderson, Proudfoot, and Harris 2009; Gorman and Brooks 2009; 
Thistlethwaite and Topps 2009; Hooker 2010); 
• prescribing physiotherapists (Fazey 2008); and  
• prescribing pharmacists (Ahlgrimm 1994; Anderson 1994; Ryan and Bond 1994, 
1996; Gilbert 1998; Cho 2000; Gilbert 2001; Chapman, Alford, and Brien 2002; 
Brown 2003; Maher 2004; Clements 2005b; Emmerton et al. 2005; Low 2005; 
Australian Journal of Pharmacy 2006b; Burton 2006; Kelly 2006; Gupte 2007; 
Low 2007; Roberts 2007; Fleming 2008; Nissen 2010). 
 
A combination of roles is also evident with a dispensing doctor (DD) who routinely 
prescribes and dispenses pharmaceuticals to their patients from their on-site 
dispensary.  The phenomenon of doctor dispensing pharmaceuticals is not new and 
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may be traced back to apothecaries who combined the roles of prescribing and 
dispensing drugs for their clients (Pharmaceutical Society of Australia ; Roberts 1984; 
Robinson 1984; Gould and Considine 1987; Madge 1987; Tse and Madura 1987; 
Weiss 1987; Kapil 1988; Lawborne 1989; Zuckerman 1989; Anderson 1990; Chelsea 
Pensioner 1990; Clark 1990; Goggin et al. 1990; Henson 1990; Leonard 1990; Millar 
1990; Fryklof 1994; Seo 1994; Kernick 1997; Chemist & Druggist 1999a; Gilbert 
2001; Levy 2001; Trap and Hansen 2003; Ho 2005; Phelps 2005; Dammery 2008; 
Gadiel 2008).  Currently, in many developing and developed countries 1
 
 DDs 
dispensed medicines for a variety of reasons.  These include insufficient pharmacy 
coverage, increased drug accessibility and availability for their patients, and for 
financial gain (Trap 1997; Lim et al. 2010). 
The issue of whether DDs should dispense for profit is debated amongst the 
pharmaceutical and medical professions.  Those against DDs have argued that: 
(1) conflict of interest with DDs both owning the dispensaries and prescribing has 
the potential for less judicious prescribing (Anderson 1986; Glaser 1986; 
Rundle 1986; American Pharmacy 1987a; Gould and Considine 1987; Karlitz 
1987; Olch 1987; Penna 1987; Relman 1987; Robinson 1987a; Robinson 
1987b; Weintraub and Lipman 1987; Weiss 1987; Abood 1988; Breschi 1988; 
Kapil 1988; Trytek 1988; Lawborne 1989; James 1992; Warden 1992; 
Anderson 1994; Axon 1994; Ryan and Bond 1994; Truter, Wiseman, and 
Kotze 1995; Nizami, Khan, and Bhutta 1996; Ryan and Bond 1996; Truter and 
Kotze 1996; Michalik 1998; Shepherd and Blissitt 1998; Chemist & Druggist 
1999b; Rodwin and Okamoto 2000; Gilbert 2001; Kwon 2002; Warren 2002; 
Kwon 2003; Avileli et al. 2004b, 2004a; Lim, Gray, and Roach 2004; Ho 2005; 
Daily Mail 2006; Neuhauser, Swedlow, and Wynn 2006; Iizuka 2007; Actavis 
2008a; Gadiel 2008; Iizuka 2008), 
(2) doctors are not trained to dispense hence, without a secondary check by a 
pharmacist, there is less judicious dispensing and possibly increased 
medication errors and abuse (Chambers 1984; Anderson 1986; Archambault 
1986; Glaser 1986; American Pharmacy 1987a, 1987b; Calis 1987; Gould and 
                                               
1 These include 45 states in the United States of America (USA), 13 cantons in Switzerland, the 
United Kingdom (UK) and most parts of Asia and South Africa continents. 
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Considine 1987; Karlitz 1987; Madura and Tse 1987; Tse and Madura 1987; 
Abood 1988; Lober et al. 1988; Lawborne 1989; Anderson 1990; Chelsea 
Pensioner 1990; Clark 1990; Disgusted of Dorset 1990; Gall 1990; Goggin et 
al. 1990; Heller 1990; Galvo and Hyman 1993; Ahlgrimm 1994; Anderson 
1994; Axon 1994; Borzo 1994; Ryan and Bond 1994; Brelis 1995; Lee 1996; 
Elmfield Drugs Ltd & Anor, R (on the application of) v Family Health Services 
& Anor  1998; Bosch 1998; Chemist & Druggist 1998; Cousins and Upton 
1999; Gilbert 2001; Pharmaceutical Society of Australia 2001; Ashley, Kirk, 
and Fowler 2002; Kwon 2002; Warren 2002; Kwon 2003; Avileli et al. 2004b, 
2004c, 2004a; Drug Week 2004; Singapore Medical Association 2004; Goh 
2006; Rhew 2008; The Atlanta Journal and Constitution 2008; Truesdell 2008; 
US Fed News Service 2008; Zoltay 2008; Kernick 1997; Millar 1990; Retief 
1987; Robinson 1984, 1987a; Robinson 1987b; Rodwin and Okamoto 2000; 
Seo 1994; Madge 1987; Madge 1990; Smith et al. 2004; Takemasa 1994; Trap 
1997; Trytek 1988; Weiss 1987; Williams 1995; Shepherd and Blissitt 1998; 
Penna 1987; Hunt 2001; Breschi 1988; Relman 1987; Warden 1992; Kapil 
1988; Efrat 2004; Ho 2005; Day 2002; Lee 2004; Wong 2004; Taylor, Mrazek, 
and Mossialos 2004), and  
(3) patients are deprived of choice of those from whom they want their 
pharmaceuticals dispensed (Langston 1986; Engman 1987; Nelson 1987; 
Warden 1992; Actavis 2008d). 
 
Advocates for DDs have often contended that doctor dispensing increases patients’ 
compliance and convenience (Nystrom and Clark 2006; Shepherd and Blissitt 1998; 
Tshabalala-Msimang 2004; Medical Letter on the CDC & FDA 2007; Kistruck 2002; 
Glaser 1986; Anderson 1986; Collinge 1993; Emrys-Jones 1993; Garrett 1989; 
Ferguson 1998; Aranson 1987; Levy 2001; Borfitz and Haines 2001; Lee 2000; 
Jones 2002; Jeffries 2001; Holland 2001; Finlayson 2001; Baird 2000; Efrat 2004; 
Gerbrands 1994; Shankar 2007; Walters 2003; Cromer Group Practice 2004; Glynn 
2003; Keeton 2004; Epilepsy Action 2003; Country Doctor 2004; Rappo et al. 1995; 
McCormack 1993; McClallen 1914; Wardle 1914; Gould and Considine 1987; Kahn 
2004; Ho 2005; James 1992; Kamdar 2001; The Lancet 1973; Faisst, Schilling, and 
Gutzwiller 2000; Lim, Gray, and Roach 2004; Lim and Russell 2005; Ogbogu et al. 
2001; Hyde et al. 1979; Trap 1997; Langston 1986; Furber 1969; The Lancet 1969; 
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Mabaso and Trichardt 2004; Kapil 1988; Phelps 2005; Dispensing Doctors' 
Association 2004; Rundle 1986; Borfitz 2001; Actavis 2008c; Lawborne 1989), and 
that there is no evidence that DDs prescribe less judiciously or are more expensive 
(Geedes 1992; Stewart-Brown et al. 1996; Willis 1996; Roberts 1992; Smith 1993; 
Thomas 1992; GP 2008; Tennant 2008; Ward 2003, 2004; Baker 2008; Tennant 
2006b, 2007; Actavis 2008b; Vos 2004; Wilcock and Mackenzie 2000; Wilcock 
2002; Dunn and Beswick 1993; Wilcock 2003; Ward 2002; Zuckerman 1989; 
Thomas 2004; Tennant 2006a, 2006c; Meakin 2004; Trap 1997; Lee 2004; Wong 
2004). 
 
The practice of doctor dispensing in many countries is subject to legislative control 
(Abood 1988; Huston 1987; Lim, Gray, and Roach 2004; Relman 1987; Zuckerman 
1989; Efrat 2004; Williams 1995; Seo 1994; Ho 2005; Thomas 2004; Watt 1993; 
The Lancet 1973; Rodwin and Okamoto 2000; Smetherham 2004; Keeton 2004; 
Meakin 2003; Rundle 1986; Gilbert 2001; Robinson 1984; Avileli et al. 2004c; 
Mabaso and Trichardt 2004; Health Professionals Act 2004 (ACT)  2004; Pharmacy 
Act 1964 (NSW)  1964; Poisons and Dangerous Drugs Act 2007 (NT)  2007; Health 
Act 1937 (Qld)  1937; Health (Drugs and Poisons) Regulation (Qld)  1996; 
Controlled Substances Act 1984 (SA)  1984; Poisons Act 1971 (Tas)  1971; Drugs, 
Poisons and Controlled Substances Act 1981 (VIC)  1981; Poisons Act 1964 (WA)  
1964; National Health Act 1953 (Cth)  1953; Nystrom and Clark 2006; NHS 
Employers and British Medical Association 2006; Actavis 2008c; Office of Inspector 
General 1989; Pharmaceutical Services Branch 2003; East Cambridgeshire and 
Fenland NHS 2001; Martin 1989; Pharmaceutical Society of Australia 2001; 
Sullivan 1987; South African Press Association 2004; Robinson 1987a; Blake and 
Slotnik 1980; Elmfield Drugs Ltd & Anor, R (on the application of) v Family Health 
Services & Anor  1998; Re HEDGE (as administrator of Goldfields Medical Fund 
Inc (admin apptd) (No 2)  2002; Sidley 1996; Keddie 2003).  Under current 
Australian legislation, doctors are only permitted to dispense and supply medicines 
as pharmaceutical benefits in areas where they practise if there is no pharmacy 
available within a reasonable geographical distance (Lim, Gray, and Roach 2004).  
Consequently Australian DDs are often located in isolated rural and remote 
communities (Pharmaceutical Society of Australia 2001; Efrat 2004; Lim, Gray, and 
Roach 2004; Lim and Russell 2005; Sunderland, Burrows, and Joyce 2006).  They 
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are generally perceived as integral members of rural healthcare by providing their 
patients with timely and convenient access to both medical and pharmaceutical care 
(Lim, Gray, and Roach 2004; Efrat 2004; Leknys 2008).  However, there is a general 
expectation in Australia that DDs do not dispense primarily for income (Efrat 2004; 
Lim, Gray, and Roach 2004; Gadiel 2008), even though the ability of these rural and 
remote doctors to earn a profit by dispensing pharmaceutical benefits for their 
patients may be an important financial incentive in retaining rural doctors in small 
country towns and in ensuring the viability of what would be an otherwise unviable 
and therefore unsustainable rural practice (Winstanley 1969; The Lancet 1973; 
Beecham 1995; Kamdar 2001; Lim, Gray, and Roach 2004; Light 2005b; Lim and 
Russell 2005; Sunderland, Burrows, and Joyce 2006; Actavis 2008e). 
 
Health expenditure has increased dramatically in all countries in recent times 
(Anderson et al. 2000; Hailey 1997; Australian Institute of Health and Welfare 2005a, 
2006a, 2009; Australian Journal of Pharmacy 2005a; Prados-Torres et al. 2009).  
Contributing factors include:  
• Demographic change: ageing of the population changes the availability of 
workforce and the nature of the services required (Duckett 2005a; Hugo 2005; 
Sewell 2005; Britt et al. 2009; Gunn 2009; Jiwa, Carlsen, and Horner 2009; Scott 
2009; Brooks 2010). 
• Epidemiologic change: the increase in prevalence of chronic diseases affects the 
nature and functions of the service model and workforce required (Sewell 2005; 
Australian Institute of Health and Welfare 2006b; Duckett 2006; Britt et al. 2009; 
Jiwa, Carlsen, and Horner 2009). 
• Workforce values change: intergenerational attitudes towards work, leisure and 
family are affecting workforce availability and work patterns (Tolhurst and 
Stewart 2004; Duckett 2005a; Carnell 2006; Gunn 2009), and there is more focus 
on healthcare teams and new way of working (Gunn 2009; Brooks 2010). 
• Lifestyle values change: the formation of more influential sea-change and tree-
change communities (Duckett 2005a; Hugo 2005), international migration of 
health professions (Duckett 2005a; Hugo 2005), and rising community 
expectations and demand for more proactive care (Sewell 2005). 
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• Technology change: advances in information and communication technologies 
have contributed to empowered health consumers and a demand for more 
efficacious pharmaceuticals which are more expensive (Duckett 2005a). 
• Climate change: changing climatic patterns are potentially affecting the nature of 
diseases and service response required (Green et al. 2009; Inglis 2009; 
McMichael and Butler 2009; Veitch 2009); this is also likely to exacerbate the 
uncertainty of climate-dependent outcomes in industries like farming potentiating 
greater migration of younger people to cities which results in an increasing 
proportion of older adults in rural communities who might be geographically 
isolated and have limited social and family networks (Beard et al. 2009). 
• Economic change: there is widening health outcome disparity between urban and 
rural (Gunn 2009; Haikerwal 2009a); the recent 2007-9 global economic crisis 
has arguably widened the inequities in health between socio-economic groups 
(Gunn 2009; Scanlan and Bundy 2009; Stocks et al. 2009; Ward 2009) and 
money required is harder to obtain (Haikerwal 2009a). 
 
In response, policymakers have reacted with a series of healthcare reforms and 
measures to guarantee the sustainability of their healthcare system (Lee and Crupi 
2001; Kwon 2002; Harvey, Harris, and Bulfone 2007; Towler 2007; Australian 
Medical Association 2009; Bennett 2009; Commonwealth Department of Health and 
Ageing 2009d; National Health and Hospitals Reform Commission 2009; National 
Preventive Health Taskforce 2009; Russell, Hogg, and Lemelin 2010).  One common 
measure employed by western countries public health insurers is to significantly 
increase the amount of co-payment that insurees are required to pay for their 
pharmaceutical benefits (Crichton 1990; Australian Journal of Pharmacy 2005a, 
2005e; Australian Medical Association 2005a; Fleming 2005a, 2005b; Frank 2005; 
Pharmaceutical Defence Ltd 2005; Walters 2005; Tatchell 2006; Bracey 2007b; 
Nicholson 2007). 
 
Previous evidence has indicated that pharmaceuticals have low cross-elasticity, 
unlike other commodities of trades (Tellis 1988).  However, recent Australian study 
has confirmed the suspicion that rising pharmaceutical costs do have a negative 
impact on patient adherence to medical treatments: patients who struggle to afford 
their medicines may reduce or skip doses to make prescriptions last longer, or stop 
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taking some pharmaceuticals altogether (Ross and Macleod 2005; Hynd et al. 2008; 
Hynd 2008; Tatchell 2008, 2009).  Economic crisis is known to impact on the 
distribution of healthcare utilisation: the use of medical services by lower-income 
groups is more severely affected than use by high-income groups (Kwon 2002).  
Therefore, in light of the recent global economic crisis, health disparity between 
high- and low-income groups may be exacerbated with increased pharmaceutical 
costs: the poor become poorer in health.  There have been suggestions that DDs 
might be more responsive to patient costs than to their own profits (Lim, Gray, and 
Roach 2004; Iizuka 2007, 2008). 
 
1. PURPOSE STATEMENT 
 
The objective of this thesis is to conduct a summative evaluation of the prescribing 
practices of Australian DDs.  The study proposed to gather data on differences in 
pharmaceuticals prescribing between Australian DDs and non-DDs, and to 
subsequently seek explanation from DDs for the identified differences.  This study 
utilised two-phase sequential explanatory mixed methods (QUANqual): firstly, 
quantitative data from claims made to the Australian national health insurer, 
Medicare, were analysed; secondly, qualitative interviews were conducted to 
elaborate on and clarify findings from the quantitative analyses.  Outcomes from this 
study will inform governments’ policies on doctor dispensing. 
 
This thesis is structured on the mixed methods publication framework proposed by 
Onwuegbuzie (Onwueguzie and Leech 2006; Onwuegbuzie and Collins 2009).  In 
Chapter II, the dissertation presents a systematic review conducted between 
November 2007 and January 2009 which systematically and comparatively appraised 
the research evidence related to the practices of DDs.  To present the overall 
framework of the Australian Dispensing Doctors (ADD) Study, Chapter IV outlines 
the formulation of the research objectives and presents the rationale for mixing 
quantitative and qualitative methods in this study.  Chapter IV also presents the 
quantitative methodology.  Chapter V outlines the quantitative results and initial 
interpretation of the findings.  Chapter VI provides the linkage between the 
quantitative and the qualitative phases of the study.  It outlines the selection of 
quantitative findings explored through the qualitative phase of the ADD Study and 
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the qualitative methodology.  Chapter VII presents the qualitative results.  Chapter 





II. LITERATURE REVIEW 
 
 
Knowledge about DD’s prescribing habits is very limited and discussions on doctor 
dispensing are plagued by emotional and anecdotal reports and statement.  This 
systematic review was undertaken with the objective of analysing critically existing 




For this systematic review, the term ‘dispensing doctor’ was broadly defined as any 
medical practitioner who undertakes the role of dispensing pharmaceutical products/ 
benefits in situations that would normally be regarded as the practice of a pharmacist. 
 
1.1. Search Strategy 
 
Potentially relevant papers related to DDs were identified through searches of six 
common electronic databases (Pro Quest™, Medline™, Science Direct™, Embase™, 
Web of Science™ and Cochrane Library™) and by direct contact with authors of 
included papers to obtain further articles.  It was reported elsewhere that the 
sensitivity of a conventional Medline™ search was approximately 51% (Dickersin, 
Scherer, and Lefebvre 1995)(p27), therefore additional searches were also conducted 
using Google Scholar™ and Yahoo™.  The “snowball” method was also utilised: 
bibliographies of all included papers were further examined and additional articles 
were then retrieved.  The final search included publications until December 2008.  
See Figure 2.1 for the selection process of eligible papers. 
 
The search terms used in the electronic search were:  
• dispensing doctor,  
• dispensing physician, and 




The Medical Subject Headings (MeSH) include:  
• prescription practice,  
• prescribing behaviour, 





Figure 2.1:  Selection process of eligible papers. 
 
  
254 potentially relevant papers 
 Pro Quest Medline Science Direct Embase Web of Science Cochrane 
dispensing 10 267 3 013 2 499 47 3 238 143 

































 89 individual unique papers 
Inclusion criteria: 
 Written in English 
 Published between January 1970 and December 2008 
 Quantitative data on medical practitioners who routinely dispensed pharmaceuticals 
+ 165 individual papers 
from snowball search 
Exclusion criteria:  
• informal discussion and individual opinions (212 papers) 
• qualitative papers (2 papers): (Lim, Gray, and Roach 2004; Lim and Russell 2005) 
• only abstract in English (1 paper): (Faisst, Schilling, and Gutzwiller 2000) 
• not designed to evaluate dispensing doctors’ practices (6 papers): (Kang, Park, and Kim 2002; Morton-Jones and Pringle 1993a; Ross and 
Macleod 2005; Stewart-Brown et al. 1995; Watkins et al. 2003; Whynes, Baines, and Tolley 1995) 
• did not provide adequate controls (10 papers): (Andritz and Rogan 1988; Ashley, Kirk, and Fowler 2002; Cousins and Upton 1999; Galvo 
and Hyman 1993; Iizuka 2007; Nizami, Khan, and Bhutta 1996; Siddiqi et al. 2002; Truter, Wiseman, and Kotze 1995; Truter and Kotze 
1996; Lawborne 1989) 
• only selective findings and no mention of methodology (2 papers): (Drug Tropics 2001; Medical Letter on the CDC & FDA 2007) 
Papers included: 
 Drug utilization 
o Volume (Sunderland, Burrows, and Joyce 2006; Morton-Jones and Pringle 1993b; Trap and Hansen 2002b; Trap, Hansen, and 
Hogerzeil 2002; Baines, Tolley, and Whynes 1996; Wilcock 2001) 
o Generic prescribing (Baines, Tolley, and Whynes 1996; Trap, Hansen, and Hogerzeil 2002; Wilcock 2001; Baines and Whynes 1997) 
o Cost of pharmaceuticals (Baines, Tolley, and Whynes 1996; Gavaza, Maponga, and Mukosera 2008; Morton-Jones and Pringle 1993b; 
Wilcock 2001) 
 Effectiveness of separation policy 
o South Korea (Lee and Malone 2003; Park et al. 2005) 
o Taiwan (Chou et al. 2003) 
 Prevention of adverse events (Trewin et al. 1996) 
 Adherence to best practice (Trap and Hansen 2002b; Park et al. 2005; Trap and Hansen 2002a) 
 Quality of dispensing (Hansen and Trap 2004) 
 Stakeholder perspectives on doctor dispensing 
o Patients’ perspectives (Sunderland, Burrows, and Joyce 2006; Perri et al. 1987; Pink, Hageboeck, and Moore 1989; Ogbogu et al. 
2001) 
o Doctors’ perspectives (Ogbogu et al. 2001; Hyde et al. 1979; McRoberts 1987; Holiday et al. 1992; Gilbert 1998) 
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1.2. Inclusion and Exclusion Criteria 
 
Inclusion criteria for paper selection were that they: 
• were written in English;  
• were published between January 1970 and December 2008; and 
• provided quantitative data comparing the practice of DDs and non-DDs as part of 
ordinary clinical practice. 
 
Exclusion criteria used for publications were that they: 
• were opinions or editorials about the dispensing profession and/or practice; or  
• were not designed to specifically evaluate DDs’ practices. 
 
1.3. Data Extraction 
 
Potentially relevant papers from database searches were reviewed at abstract level.  
Abstracts of articles deemed relevant were retrieved and reviewed.  Full articles of 
original papers were obtained and analysed according to relevance and types of 
information based on the hierarchy of study design used by the Scottish 
Intercollegiate Guidelines Network (SIGN) (Harbour and Miller 2001). 
 
A specifically-developed data extraction sheet (see Appendix B), which was 
consistent with the Quality of Reporting of Meta-analyses (QUOROM) statement 
(Moher et al. 2000) was used to collect information on all analytical papers.  This 
included the country, sample demographics, study design, methodology, detailed 
wordings of the original authors’ conclusions and findings.  The decision whether a 
paper was to be included and the SIGN ranking were reached by consensus by at 







The initial database search identified 89 individual papers and the subsequent 
snowball-search of these papers provided another 165 papers (see Figure 2.1).  
 
Of the 254 papers retrieved and assessed for quality, 212 belonged to SIGN levels 3 
and 4, namely: political discussions, discussions related to professions, individual 
opinions and views, brief descriptions of regulations and laws pertaining to 
dispensing, papers addressing historical aspects of DDs, articles related to 
pharmaceutical repackaging, mail order or media reports.  These did not include 
primary data suitable for the purpose of this review and were excluded.  No 
systematic reviews or meta-analyses published on DDs could be found.  Two 
qualitative papers (Lim, Gray, and Roach 2004; Lim and Russell 2005) were 
identified from the search but due to the methodologies employed, they did not meet 
inclusion criteria.  It was also decided that a meta-ethnography was premature at this 
time. 
 
Of those remaining, one paper was excluded as only the abstract was in English 
(Faisst, Schilling, and Gutzwiller 2000), and six papers were excluded as the studies 
were not designed to specifically evaluate the practices of DDs (for example effects 
of fund-holding on practices across catchments) (Kang, Park, and Kim 2002; 
Morton-Jones and Pringle 1993a; Ross and Macleod 2005; Stewart-Brown et al. 
1995; Watkins et al. 2003; Whynes, Baines, and Tolley 1995).  Ten papers were 
excluded due to the absence of an adequate comparison group (for example 
comparing dispensing general practitioners vs. non-dispensing medical specialists) 
(Andritz and Rogan 1988; Ashley, Kirk, and Fowler 2002; Cousins and Upton 1999; 
Galvo and Hyman 1993; Nizami, Khan, and Bhutta 1996; Siddiqi et al. 2002; Truter, 
Wiseman, and Kotze 1995; Iizuka 2007; Lawborne 1989); and two papers did not 
describe their methodology (Drug Tropics 2001; Medical Letter on the CDC & FDA 
2007). 
 
Finally, 21 papers were included in this systematic review on the comparisons of 
DDs and non-DDs’ practices.  The selected papers summarised in Table 2.1 were 
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from the USA (6), the UK (5), Zimbabwe (5), South Korea (2), Australia (1), South 
Africa (1), and Taiwan (1).  The papers were categorised into the following areas: 
• drug utilisation, 
• effectiveness of separation policy, 
• prevention of adverse events, 
• adherence to best practice, 
• quality of dispensing, and 
• stakeholder perspectives on DD. 
 
 
Paper Methodology Sample Period Country SIGN 
(Sunderland, Burrows, 
and Joyce 2006) Postal survey 7 DDs vs. 7 non-DDs 
January – 



















(Park et al. 2005) Comparative study 







(Chou et al. 2003) Comparative study 2 DDs vs. 2 non-DDs 
December 1996 





59 DD practices vs. 49 
non-DD practices 1990/1 UK 2+ 




59 DD practices vs. 49 
non-DD practices 1990/1 – 1993/4 UK 2+ 
(Trewin et al. 1996) Comparative study 
906 DDs’ patients vs. 3448 
community pharmacists’ 
clients 
July 1984 – 
November 1993 UK 2+ 




55 DD practices vs. 50 
non-DD practices 1993/4 UK 2+ 
(Wilcock 2001) Comparative study 10 DDs vs. 10 non-DDs 1997/8 UK 2++ 
(Hyde et al. 1979) Postal survey 16 practices 1976 USA 3 
(McRoberts 1987) Telephone survey 203 doctors -- USA 3 
(Perri et al. 1987) Telephone survey 539 households -- USA 2- 
(Pink, Hageboeck, and 
Moore 1989) Postal survey 2400 adults 1987 USA 2- 
(Holiday et al. 1992) Postal survey 800 doctors -- USA 3 
(Ogbogu et al. 2001) Postal survey 168 doctors 1998 USA 3 
(Trap, Hansen, and 
Hogerzeil 2002) 
Comparative 
study 29 DDs vs. 28 non-DDs April – July 1997 Zimbabwe 2++ 
(Trap and Hansen 
2002b) 
Comparative 
study 29 DDs vs. 28 non-DDs April – July 1997 Zimbabwe 2++ 
(Trap and Hansen 
2002a) 
Comparative 
study 28 DDs vs. 25 non-DDs April – July 1997 Zimbabwe 2+ 




29 DD dispensaries vs. 20 
pharmacies 1997 Zimbabwe 2- 




23 DD dispensaries vs. 35 
pharmacies -- Zimbabwe 2- 
Table 2.1: Summary of papers included in the systematic review.  
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2.1. Drug Utilisation 
 
Seven papers provided empirical data on drug utilisation of DDs.  See Table 2.2 for 





Trap conducted a comparative study of 29 DDs and 28 non-DDs in Harare, 
Zimbabwe for her PhD (Trap 2001).  On average 30 patients’ records were randomly 
selected and retrospective data collected from each doctor.  The author found that 
DDs prescribed significantly more pharmaceutical items per consultation than non-
DDs (2.3 [2.1 – 2.6] vs. 1.7 [1.5 – 2.0], p = 0.001) (Trap, Hansen, and Hogerzeil 
2002).  This included more injections (0.30 [0.20 – 0.41] vs. 0.10 [0.04 – 0.15], p = 
0.002) and mixtures (0.43 [0.33 – 0.53] vs. 0.25 [0.19 – 0.31], p = 0.005).  A further 
analysis of these patients’ records found that DDs prescribed more pharmaceutical 
items than non-DDs in the treatment of upper respiratory tract infections (total drugs: 
2.77 [2.49 – 3.06] vs. 1.96 [1.77 – 2.16]; injections: 0.38 [0.25 – 0.50] vs. 0.13 [0.05 
– 0.21]; mixtures: 0.92 [0.73 – 1.12] vs. 0.57 [0.44 – 0.70]) (Trap and Hansen 2002b). 
 
Findings from England were somewhat similar.  Morton-Jones and Pringle (1993b) 
accessed the prescribing data for all 108 general practices within Lincolnshire Family 
Health Services Authority catchments and found that DDs prescribed more 
pharmaceutical items per patient than non-DDs (9.55 vs. 8.32, p < 0.05) in the 1990-
1 fiscal year.  This was reaffirmed by Baines et al. using 1993-4 fiscal year 
prescribing data from the same health catchments (11.5 vs. 9.7, p < 0.05) (Baines, 
Tolley, and Whynes 1996).  In a separate study, Wilcock (2001) analysed the 
prescribing data for ten matched pairs of DDs and non-DDs within Cornwall and 
Isles of Scilly Health Authority catchments and found that DDs prescribed 13% more 
pharmaceutical items per patient than non-DDs (11.82 [10.97 – 13.48] vs. 10.44 
[8.76 – 11.44], p = 0.007). 
 
Preliminary findings from Australia conversely seemed to suggest otherwise.  
Sunderland et al. in a survey of seven matched pairs of DDs and non-DDs in Western 
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Australia (WA), found that 78,186 prescriptions were dispensed by DDs as compared 
with 84,720 prescriptions dispensed in towns with a pharmacy (non-DDs) 
(Sunderland, Burrows, and Joyce 2006; Sunderland, Burrows, and Joyce 2005). 
 
2.1.2. Generic Prescribing 
 
The use of generic pharmaceuticals is of interest to health economics because generic 
pharmaceuticals are usually cheaper than branded pharmaceuticals, and hence 
contribute to a sustainable health system (Glasson 2004; Stokes 2008; Lofgren 2002; 
Nicholson 2007; Searles et al. 2007; Nicholson 2008; Gupte 2008; Mouala et al. 
2008; Stewart-Brown et al. 1996; Clarke and Fitzgerald 2010). 
 
In Zimbabwe, Trap et al. reported that 43.7% of DDs’ prescriptions were prescribed 
generically as compared to 43.6% of non-DDs’ (Trap, Hansen, and Hogerzeil 2002).  
In England, Morton-Jones found that DDs prescribed less often generically than non-
DDs (26.5% vs. 42.0%, p < 0.001) (Morton-Jones and Pringle 1993b).  This was 
further supported by Baines et al. (28.9% vs. 46.5%, p = 0.00) (Baines, Tolley, and 
Whynes 1996) and Wilcock (45.0% vs. 63.3%, p = 0.007) (Wilcock 2001). 
 
2.1.3. Cost of Pharmaceuticals 
 
Gavaza et al. conducted a price survey of 35 pharmacies and 23 DDs’ dispensaries 
across five different provinces in Zimbabwe (Gavaza, Maponga, and Mukosera 
2008).  The authors reported that of the 37 generic essential pharmaceuticals 
surveyed, 18 - 22 of them were significantly more expensive from DDs than in 
pharmacies. No further information was provided and the principal author has not 
responded to repeated requests for more information. 
 
Across the Lincolnshire Family Health Services Authority, Morton-Jones and Pringle 
reported higher net ingredient costs per patient from DDs than non-DDs (1990-1: 
£54.78 vs. £48.47, p < 0.05) (Morton-Jones and Pringle 1993b).  This was confirmed 
by Baines et al. (1991-2: £67.80 vs. £58.20, p < 0.05; 1992-3: £75.60 vs. £64.50, p < 
0.05; 1993-4: £85.60 vs. £70.01, p = 0.003) (Baines, Tolley, and Whynes 1996).  
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However, Wilcock reported no statistically significant differences in the Cornwall 




As outlined in Table 2.2, there is some level B evidence to indicate that DDs’ 
practices prescribed more items per patient per year (mean difference [MD] = 2.00, 
standard error of a difference [SED] = 0.22, d = 1.04 [0.79 – 1.29], t = 8.93, p = 
0.035), and had modestly higher pharmaceutical costs per patient per year (MD = 
8.36 [SED 1.48], d=0.45 [0.29 – 0.61], t = 5.64, p = 0.012).  There was no statistical 
significant evidence that DDs prescribed generic pharmaceuticals less frequently 






 DD NDD P Diff 
(%) 
Sample Ref 
Mean number of items 





11.50 9.70 0.001* +15.65 1993-4: 59 DD practices vs. 49 non-DD practices 
(Baines, Tolley, and 
Whynes 1996) 
8.85 5.26 - +40.56 29 DDs vs. 28 non-DDs (Trap, Hansen, and Hogerzeil 2002) 
9.55 8.32 <0.05* +12.88 1990-1: 59 DD practices vs. 49 non-DD practices 
(Morton-Jones and 
Pringle 1993b) 
11.82 10.44 0.007* +11.68 10 DDs vs. 10 non-DDs (Wilcock 2001) 
Mean net ingredient 





58.40 50.30 0.001* +13.87 
1990-1: 59 DD practices vs. 
49 non-DD practices 
(Baines, Tolley, and 
Whynes 1996) 
67.80 58.20 0.00* +14.16 
1991-2: 59 DD practices vs. 
49 non-DD practices 
(Baines, Tolley, and 
Whynes 1996) 
75.60 64.50 0.00* +14.68 
1992-3: 59 DD practices vs. 
49 non-DD practices 
(Baines, Tolley, and 
Whynes 1996) 
85.60 70.10 0.003* +18.11 
1993-4: 59 DD practices vs. 
49 non-DD practices 
(Baines, Tolley, and 
Whynes 1996) 
54.78 48.47 0.002* +11.52 




101.69 102.14 0.333 -0.44 10 DDs vs. 10 non-DDs (Wilcock 2001) 
Percentage of items 




28.9 46.5 0.00* -60.90 
1993-4: 59 DD practices vs. 
49 non-DD practices 
(Baines, Tolley, and 
Whynes 1996) 
43.7 43.6 - +0.23 29 DDs vs. 28 non-DDs (Trap, Hansen, and Hogerzeil 2002) 
26.5 42.0 <0.001* -58.50 




43.5 62.5 - -43.68 10 DDs vs. 10 non-DDs (Wilcock 2001) 
97.73 88.49 - +9.45 
Peptic ulcer scripts: 4481 
DDs’ vs. 50680 non-DDs’ 







39.4 28.9 NS +26.65 29 DDs vs. 28 non-DDs (Trap and Hansen 2002b) 
80.8 72.8 <0.001* +9.90 
Scripts: 26414 DDs’ vs. 
24585 non-DDs’ 
(Park et al. 2005) 
41.4 43.5 NS -5.07 28 DDs vs. 25 non-DDs (Trap and Hansen 2002a) 
Table 2.2:  Summary of factors identified for dispensing and non-dispensing 






2.2. Effectiveness of Separation Policy 
 
Three papers were identified that studied the effects of a government policy to 
separate the roles of dispensing from prescribing (Chou et al. 2003; Lee and Malone 
2003; Park et al. 2005).  These papers were from South Korea (2) and Taiwan (1). 
 
2.2.1. South Korea 
 
There have been global interests in separation of dispensing and prescribing (Lee and 
Crupi 2001; Kwon 2002, 2003; Seo 1994; Rodwin and Okamoto 2000; Iizuka 2008; 
Ho 2005; Tan 2006; Goh 2006).  In recent times South Korea introduced a 
controversial compulsory separation of dispensing from prescribing policy in July 
2000 (Watts 2000; Lee and Crupi 2001; Ahmad 2000; Kwon 2003; Cho 2000; Watts 
2001).  This policy prevented all doctors from dispensing pharmaceutical products to 
their patients.  It was expected that following the implementation of the policy, the 
use of pharmaceuticals in South Korea would decrease since pharmacists would alert 
doctors and patients to possible adverse reactions, thus reducing the use of 
pharmaceuticals. 
 
Lee and Malone (2003) used the South Korean national health insurance claims data 
to assess changes in peptic-ulcer medication prescribing six months before and after 
the implementation of this policy.  It was found that whilst the number of all 
prescriptions increased by 13.9% following the implementation of the policy, the 
total number of peptic-ulcer medication prescriptions decreased by 39.8%.  
Interestingly, pharmaceutical expenditure for peptic-ulcer medications increased by 
98.4% during this period despite the decreased prescription volume.  The authors 
attributed this phenomenon to increased use of branded peptic-ulcer medications: 
DDs profited from direct selling of pharmaceutical products hence a preference 
towards generic products which on average had a higher profit margin; once the 
financial incentive was removed, it appears that doctors preferred to prescribe 
branded drugs that may be more familiar to patients.  Other possible reasons for this 




Park et al. (2005) also utilised the same databank for the same period but focused 
instead on the prescribing of antibiotics for respiratory tract, urinary tract and soft 
tissue infections.  The authors found that following the separation policy, the 
proportion of antibiotic prescriptions for likely bacterial and viral illnesses decreased 
(bacterial: 92% to 90%, RR 0.98 [0.97 - 0.99], p = 0.017; viral: 81% to 73%, RR 
0.89 [0.86 - 0.91], p < 0.001), with a greater reduction seen in viral illness (p < 
0.001).  The authors also reported a decrease in antibiotic polypharmacy in both 
likely bacterial and viral illness (bacterial: 1.7 to 1.6 antibiotics per episode, ratio 
0.94 [0.92 - 0.96], p < 0.01; viral: 1.5 to 1.4, ratio 0.92 [0.90 - 0.95], p < 0.01), but 
there was no significant difference between the two groups (p = 0.357).  The authors 





Unlike South Korea, Taiwan phased in its separation policy on an incremental basis 
over four years beginning March 1997 (Chou et al. 2003).  To compensate for the 
loss of revenue from pharmaceutical dispensing, doctors’ consultation fees were 
increased and pharmacist’s dispensing fees were doubled (Chou et al. 2003). 
 
Chou et al. (2003) utilised the difference-in-difference framework to analyse the 
impact of the separation policy on Taiwan’s health and pharmaceutical expenditure.  
Using the Bureau of National Health Insurance claims data the authors found 
decreased pharmaceutical expenditure (mean: –US$1.21 [SE 0.24], p < 0.001), 
primarily through reducing the probability of providing a prescription by some 17% 
to 34% across sites.  Total health expenditure did not significantly decrease (mean: –




Level C evidence suggested that government policy to terminate doctor dispensing 
may have reduced total prescribing but with less predictable effects on health 




2.3. Prevention of Adverse Events 
 
An issue often included in the debate over doctor dispensing is the importance of a 
secondary check by a pharmacist.  To compare the effectiveness of pharmacists and 
DDs in reducing adverse drug events, Trewin et al. (1996) examined 4,544 UK 
hospital admissions for adverse drugs effects over a ten-year period.  The authors 
measured drugs levels of digoxin, phenytoin and theophylline in patients admitted 
for adverse drugs events and found that DDs had no statistically significant 
difference to pharmacists in contributing to the rate of hospitalisation from adverse 
drug events (9.4% vs. 8.4%) or in the proportion of patients found non-compliant 
(1.8% vs. 1.3%).  A power determination could not be made from the data provided 
and the authors were unable to provide further information citing lapse of time. 
 
2.4. Adherence to Best Practice 
 
Three papers investigated the quality of DDs’ use of antibiotics as a surrogate 
measure of adherence to best practice (Trap and Hansen 2002b; Park et al. 2005; 
Trap and Hansen 2002a).  These papers were derived from two comparative studies 
based in South Korea and Zimbabwe (see Table 2.2). 
 
As mentioned previously, Park et al. (2005) inferred improved quality of antibiotic 
prescribing from a reduction in the rate of antibiotic use in probable viral illnesses 
and antibiotic polypharmacy following the South Korean separation policy.  The 
authors found decreased proportion of antibiotic prescriptions, especially for likely 
viral illnesses (RR 0.89 [0.86 - 0.91], p < 0.001). 
 
In Zimbabwe, Trap and Hansen (2002b) compared retrospective patients’ records to 
assess antibiotics used in upper respiratory tract infections.  The authors reported that 
antibiotic prescribing was not justified in 39.4% of the DDs’ cohort compared with 
28.9% from the non-dispensing cohort.  The authors stated that ‘the difference was 
not significant’; no power or other statistical data were provided.  Trap and Hansen 
(2002a) also investigated the frequency of sub-curative dosages of antibiotics (≤2.5 
days) and found DDs were less likely to prescribe curative dosages (45.2% [33.9 – 
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56.5] vs. 74.2% [64.6 – 83.7], p = 0.0003).  This was confirmed by a sub-analysis of 
cotrimoxazole use (58.0% [46.9 – 69.2] vs. 72.6% [64.5 – 80.7], p = 0.047). 
 
In summary, level C evidence suggests that DDs’ practices were associated with 
modestly poorer adherence to best practice especially in terms of antibiotic 
prescribing (MD = 5.47 [SED 0.86], d = 0.24 [0.17 – 0.31], t = 6.39, p = 0.292). 
 
2.5. Quality of Dispensing 
 
Hansen and Trap (2004) conducted an observational study of 29 DDs’ dispensaries 
and 20 community pharmacies in Zimbabwe to assess the quality of dispensing 
services in general accordance with the World Health Organization’s Good 
Pharmacy Practice in Community and Hospital Pharmacy (World Health 
Organization 1996).  The modified standard assessed: 
(a) service quality (10 indicators) including affordability, patient care and 
availability; 
(b) quality of medicines (20 indicators) including stock management, storage, 
packaging and quality assurance; and  
(c) dispensing quality (14 indicators) including information, labelling, staffing 
and privacy. 
 
The authors reported that dispensing doctors’ dispensing quality was low due to 
inadequate information, inadequate labelling and lack of hygiene (Hansen and Trap 
2004).  However, neither this paper nor Trap’s PhD thesis (Trap 2001) presented 
comparative data on Zimbabwe pharmacies. 
 
2.6. Stakeholder Perspectives on Doctor Dispensing 
 
2.6.1. Patients’ Perspectives 
 
Four papers were identified on patients’ attitudes towards doctors’ dispensing. These 
papers were based on questionnaire surveys conducted in the USA (Perri et al. 1987; 
Pink, Hageboeck, and Moore 1989; Ogbogu et al. 2001) and Australia (Sunderland, 
Burrows, and Joyce 2006; Sunderland, Burrows, and Joyce 2005).  
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Respondents generally indicated convenience as a main factor for them to have 
prescriptions filled by dispensing doctors: 
• (Sunderland, Burrows, and Joyce 2006; Sunderland, Burrows, and Joyce 2005): 
61% of respondents from dispensing doctor towns disagreed with “There is too 
long a delay for obtaining my medication”; 
• (Perri et al. 1987): 70.3% agreed with the statement “Having the doctor fill my 
prescription would be more convenient than having it filled at a pharmacy”; 
• (Pink, Hageboeck, and Moore 1989): 46.6% expressed “less convenient” having 
“prescription refills from your doctor’s office?”; and 
• (Ogbogu et al. 2001): 23% listed “convenience” as reasons for office purchases 
of pharmaceuticals. 
 
Both Ogbogu et al. and Pink et al. indicated that patient-respondents perceived 
doctors to be more knowledgeable about pharmaceuticals than pharmacists ((Ogbogu 
et al. 2001): 55%, (Pink, Hageboeck, and Moore 1989): 50.1%).  Regardless of this, 
patients prefer the dispensing of pharmaceuticals to be performed by a pharmacist: 
• (Sunderland, Burrows, and Joyce 2006; Sunderland, Burrows, and Joyce 2005): 
62.0% of respondents from dispensing doctor towns ‘thought their town needed 
more access to pharmacy services’; 
• (Perri et al. 1987): 56.4% agreed with the statement “I would prefer a pharmacist 
dispense my medicine rather than a physician”; and 
• (Pink, Hageboeck, and Moore 1989): 68.7% agreed with the statement that “there 
is a health benefit from having the doctor write the prescription and a pharmacist 
(druggist) check and fill it”. 
 
Only one of the included papers directly addressed the patient’s perspective of doctor 
dispensing for profit and approximately 56.4% of the respondents were against the 




2.6.2. Doctors’ Perspectives 
 
This search included five papers on doctors’ attitudes towards dispensing. These 
papers were based on surveys conducted in the USA (Ogbogu et al. 2001; Hyde et al. 
1979; McRoberts 1987; Holiday et al. 1992) and South Africa (Gilbert 1998). 
 
Similar to the earlier patient’s findings, DDs generally perceived patient convenience 
as the main reason for them to dispense pharmaceutical products (Hyde et al. 1979; 
Ogbogu et al. 2001). 
 
Despite increased numbers of DDs in some countries (Dispensing Doctors' 
Association 2004; Sullivan 1987; Gilbert 1998; Morton-Jones and Pringle 1993b; 
Ryan and Bond 1994, 1996; Abood 1988; Weiss 1987; Holiday 1989), surveys of 
doctors who were not currently dispensing found that 100% of surveyed South 
African doctors (Gilbert 1998) and some 85.5% (Holiday et al. 1992) to 94% 
(McRoberts 1987) of surveyed USA doctors perceived dispensing as the role of 
pharmacists and had no desire to engage in doctor dispensing.  Of those doctor-
respondents who expressed an interest in dispensing ((Holiday et al. 1992): 10.5%) 
they were more likely to be solo practitioners, see more than 100 patients per week, 




Level B evidence indicates that convenience was cited as the main reason by both 







From the analysis (see Table 2.1), there was level B evidence that internationally, 
DDs tended to prescribe more pharmaceutical items and incurred higher 
pharmaceutical costs than their non-dispensing counterparts.  There was some 
evidence to suggest that DDs prescribed antibiotics less judiciously and were 
associated with poorer dispensing standards.  Despite the different national health 
systems in which DDs practiced, there was reasonable consistency among the studies 
included to support the notions of DDs dispensing for profit and for patients’ 
convenience. 
 
The critical question for policy-makers is whether the practice of doctor dispensing 
should be supported: balancing health outcomes and costs against workforce 
shortages and patient convenience.  
 
There are significant ongoing concerns over the lack of healthcare professionals in 
rural areas and the well-documented health disparity between urban and rural 
residents. In many countries DDs are located in rural and remote areas of unmet need 
where there is inadequate access to pharmacies and doctors.  Therefore the 
unconventional practice of doctor dispensing pharmaceutical benefits provides rural 
and remote patients with timely and convenient access to both medical and 
pharmaceutical care.  
 
However, the question remains: do increased pharmaceutical utilisation and costs 
associated with DDs’ practices warrant, when balanced against patient convenience 
and workforce retention, interventions to separate dispensing from prescribing?  
There is a recognised shortage of doctors internationally.  Can, then, the doctor’s 
time be better utilised than in dispensing? Evidence from government separation 
policies has suggested that separation of prescribing from dispensing may indeed 
reduce the level of prescribing and may even promote more judicious habits.  
However, the effects on overall healthcare costs are less predictable.  
 
The analysis has shown that DDs prescribed more than their non-dispensing 
counterparts and at greater cost to the healthcare system but there is only limited 
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evidence that DDs prescribed less judiciously or had poorer dispensing standards. 
Patient convenience is an important factor for doctors in dispensing pharmaceuticals 
particularly in areas of pharmacist and medical workforce shortage.  Therefore the 
separation of prescribing and dispensing practice is not clearly supported, 
particularly in areas where workforce needs are unmet. 
 
There are limitations relating to the conduct and interpretation of a systematic review 
of this nature.  Firstly, the practicality and appropriateness of the SIGN grading by 
the researchers are open to debate.  This is because the SIGN system lacks precision 
in allocating the grading.  Secondly, in the process of conducting this systematic 
review a general lack of high SIGN quality papers was identified.  Thirdly, in this 
review other domains of ‘quality’ such as interpersonal communication between DDs 
and patients, and structural aspects of care which include factors that may influence 
DDs’ prescribing and dispensing were excluded. 
 
Based on experience gained from conducting this systematic review, a different 
study design is needed to better encapsulate the effectiveness and efficiency of DDs’ 
practices in Australia.  The proposed methodology would have to incorporate 
measures of efficiency such as cost-effectiveness to the public insurer (Campbell, 
Roland, and Buetow 2000) and outcome measures of effectiveness such as disease-
state management.  At the same time, findings from Australia must be capable of 
being compared with overseas findings so as to provide a more comprehensive 
international understanding of doctor dispensing within a health policy context.  The 
proposed study method would also need to include other domains of ‘quality’ such as 
equity of access and continuity of care; these would assist in having a contextual 








The findings from the systematic review reported above were based on overseas 
studies in which each jurisdiction studied has own unique healthcare arrangements.  
The purpose of this chapter is to provide a brief introduction to the Australian 
healthcare system.  It aims to provide a context for the research question (Chapter I) 
and the ADD Study protocol outlines in Chapter IV. This background chapter to the 
Australian healthcare system will focus primarily on roles of general practitioners 
(GPs) and pharmacists, the general issue with rural and remote areas, and the 
Pharmaceutical Benefits Scheme (PBS). 
 
1. AUSTRALIA: A FEDERATION OF STATES AND TERRITORIES 
 
Australia is a relatively young country and the health system in place today has 
evolved from its humble beginnings as a penal colony of the British Empire (Sax 
1984) from which Australia inherited much of its legislative framework.  Even today, 
the healthcare system in Australia is similar in many respects to its UK counterpart 
(Sax 1984; de Voe and Short 2003; Crichton 1990). 
 
Modern Australia has arguably one of the world’s best healthcare model.  It is “based 
on whole person, continuing, comprehensive and coordinated care [and] has 
produced international benchmark results in longevity, patient-doctor satisfaction, 
and preventable death rates” (Royal Australian College of General Practitioners 
2009d)(p1). 
 
Australia’s national health outcomes have compared favourably with most major 
Organisation for Economic Cooperation and Development (OECD) countries 
(Donato and Scotton 1998; Hussey et al. 2004; Australian Commission on Safety and 
Quality in Healthcare 2009; Joumard, André, and Nicq 2010; Davis, Schoen, and 
Stremikis 2010) but, as a proportion of Gross Domestic Product (GDP), Australia’s 
spending on health care has been higher than many of its OECD counterparts 
(Anderson and Poullier 1999; Richardson, Walsh, and Pegram 2004; Australian 




Australia has a complex multi-jurisdictional healthcare funding system with 
governments taking a major role in the financing of health services. It involves three 
levels of governments: Commonwealth, State and Local (Western Australian Centre 
for Remote and Rural Medicine 2005; Newman, Baum, and Harris 2006; Davies et 
al. 2009). 
 
Local government authorities (e.g. municipal or shire councils) have no duty to 
provide health services to their communities but may play an active role in ensuring 
adequate health services are maintained in their catchments (Western Australian 
Centre for Remote and Rural Medicine 2005).  This varies across local governments 
dependent on need.  For instance, a number of local governments provide free or 
subsidised accommodation and/or direct financial incentives to attract a long-term 
doctor, pharmacist or other healthcare provider to their catchments (Western 
Australian Centre for Remote and Rural Medicine 2005; Davies et al. 2009).  
 
Respective State Governments have jurisdictional responsibility to provide 
healthcare services, such as public hospitals, and public health protection services, 
such as health promotion and registration of health professionals (Davies et al. 2009).  
The registration of health professionals was transferred to the Commonwealth 
Government from July 2010.  There is a recent move by the Commonwealth 
Government to take over aspects of public hospitals; details of the proposed 
‘nationalisation’ (if that is what it proves to be) are yet to be formally released. 
 
Pursuant to the Constitution of Australia, the Commonwealth Government has 
concurrent power to provide for the “peace, order and good government” of the 
Australian federation (Commonwealth of Australia Constitution Act 1990  1900).  
Since the 1946 constitutional amendment, Commonwealth Government has taken 
over the role of payment for hospital, pharmaceutical and several social welfare 
benefits and provision for medical and some dental services (Clinton 1998).  
Through the funding and control of subsidised health expenses, the Commonwealth 
Government plays a dominant role in influencing the use of health services in 
Australia (Kelly 2008): on average the Commonwealth Government funded 68% of 
42 
 
national health spending (Tatchell 2007), of which 5% was via the Medicare rebate 
(Australian Institute of Health and Welfare 2005a). 
 
2. MEDICARE AUSTRALIA 
 
The Federal Labor (Whitlam) Government first established a statutory body, the 
Health Insurance Commission (HIC) to provide for a public-funded health insurance 
scheme in 1974 (Crichton 1990).  Through the work of HIC, Medibank was 
conceived and this provided universal access to hospital treatment through a 
compulsory taxation levy proportionate to income (de Voe and Short 2003).  Under a 
subsequent Federal Labor (Hawke) Government, Medibank underwent a name 
change to Medicare in 1984, and the PBS was established (Crichton 1990). Since 
then there has been another name change in 2005 to Medicare Australia as a 
reflection of the Federal Liberal (Howard) Government commitment to universal 
health care. 
 
The statutory body Medicare Australia has responsibility for administering the 
Medicare Benefit Scheme (MBS) of which the PBS is one component.  Medicare 
Australia is in turn managed by an executive body, the Commonwealth Department 
of Health and Ageing (the “Department”). 
 
The MBS rebates some of the costs of medical and some allied health services 
provided by practitioners in private settings on a fee-for-service basis (Van Der 
Weyden and Chew 2004).  Providers may set their own fees and patients are required 
to meet the difference between the provider’s fees and the rebate. 
 
Medicare Australia also administers the Australian Childhood Immunisation Register, 
the Australian Organ Donor Register, the Practice Incentive Program for general 
practice, the rebate on health insurance, and incentives assigned under the 
Community Pharmacy Agreements and section 100 National Health Act 1953 (Cth) 




2.1. Pharmaceutical Benefits Scheme 
 
Approximately 13.5% of the national health spending is on pharmaceuticals, of 
which 84% has been funded by the Commonwealth Government through a PBS 
rebate (Australian Institute of Health and Welfare 2005a; Edmonds et al. 1993; 
Beilby and Furler 2004).  In real monetary terms, the Commonwealth Government 
paid just over AUD$6 billion in PBS subsidies in the 2005-6 fiscal year (Minister for 
Health and Ageing 2006).  This represented nearly 12% of total recurrent 
government expenditure on health (Gadiel 2008; Anderson et al. 2000).  
 
The PBS is a national scheme which aims to provide the Australian community with 
universal and comprehensive pharmaceutical coverage through subsidised access to 
necessary pharmaceutical benefits which are affordable, available and of acceptable 
standards (Harvey 2005; Commonwealth Department of Health and Ageing 2009a).  
 
A computer record is kept of all PBS prescription claims submitted by authorised 
community pharmacies or DD dispensaries to the Department for payment of a PBS 
subsidy (Commonwealth Department of Health and Ageing 2009a).  The Department 
summarises these data on the basis of the date of dispensing/ supply, the 
pharmaceutical code, minimum recipient information and prescriber information. 
 
The PBS data are potentially valuable sources of information, despite not being a 
complete data set for all community dispensed pharmaceutical products.  This is 
described in more detail under the Discussion section of Chapter V.  Nevertheless, 
analysis of PBS drug utilisation data allows trends and patterns of pharmaceutical 
use to be followed and the impact of interventions monitored (Horn et al. 2006; 
Mandryk et al. 2006; Wutzke et al. 2006).  This is also often used as a basis for 
pharmacoeconomic analysis (Edmonds et al. 1993).  
 
Internationally, pharmaceutical expenditure as a proportion of GDP and of total 
health expenditure has increased during the last 30 years, and it is expected to 
continue to rise (Prados-Torres et al. 2009).  In Australia, the PBS reportedly has the 
highest average annual growth rate over the last decade (around 12% per annum: 
(Greenwood 2009)); and it peaked at 16.9% in March 2003 (Australian Institute of 
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Health and Welfare 2005a)).  This is compared to 6% per annum for public hospital 
services, and 5% per annum for medical services (Harvey 2005).  There was a fear 
that, based on the projected growth of the PBS, by the year 2022 more would have 
been spent on PBS pharmaceutical benefits than on both public hospital and medical 
services together (Harvey 2005; Minister for Health and Ageing 2006).  Therefore in 
recent times the sustainability of the PBS has became a major consideration for the 
Commonwealth Government (Australian Journal of Pharmacy 2005a, 2005e, 2005b; 
Australian Medical Association 2005a, 2006; Bracey 2007b; Burge 2005b, 2005a; 
Fleming 2005a, 2005b; Frank 2005; Grogan 2007; Hynd et al. 2008; Minister for 
Health and Ageing 2006; Nicholson 2007; Pharmaceutical Defence Ltd 2005; Stokes 
2008; Tatchell 2006; Walters 2005).  In response the Commonwealth Government in 
recent times had reduced the amount of rebate payable (Scott 2005).  This has 
included a significant increased consumer co-payment, thereby shifting some of the 
cost of rising pharmaceutical care from the taxpayer back to the consumer.  
 
The Commonwealth Government subsidizes each PBS pharmaceutical item when the 
price of the item exceeds the patient co-payment amount.  In 2010, patients in the 
general category paid up to a maximum of AUD$33.30 for a pharmaceutical item 
listed on the PBS Schedule2
 
, while patients in concessional categories (primarily 
social security recipients or veteran affairs beneficiaries) paid a maximum of 
AUD$5.40.  During the ADD Study period, the general category co-payments were 
AUD$28.60 in 2005 and AUD$29.50 in 2006, and the concessional co-payments 
were AUD$4.60 in 2005 and AUS$4.70 in 2006 (Minister for Health and Ageing 
2006). 
There is also a safety-net provision under the PBS which operates for each of these 
categories of patient in any one calendar year.  When the limit is reached, 
pharmaceutical benefits are either free or have a much reduced co-payment for the 
remainder of the safety-net period (Beilby and Furler 2004). 
 
  
                                               
2 Previously known as the ‘yellow book’. 
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3. ROLES OF GENERAL PRACTITIONERS AND PHARMACISTS 
 
In Australia, primary care is a complex multidimensional system with GPs3 often 
being the first point of contact for health concerns (Allan, Ball, and Alston 2009; 
Gunn et al. 2008; General Practice in Australia, Health Priorities and Policies 1998 
to 2008  2009; Beilby and Furler 2004; O'Halloran et al. 2003; Powell-Davies and 
Fry 2004) and the empirical gatekeepers for the health system (Martin and Sturmberg 
2005; Powell-Davies and Fry 2004; Allan, Ball, and Alston 2009; McGrail and 
Humphreys 2009b; Barron 2006; Royal Australian College of General Practitioners 
2009b; Davies et al. 2009; Kringos et al. 2010) whilst pharmacists4
 
 adopt the role as 
gatekeepers for the PBS (Eton 2007a; Nicholson 2007). 
3.1. Roles of General Practitioner in Australia Healthcare 
 
General practice delivers the lion’s share (90%) of primary healthcare (Sanci, Kang, 
and Ferguson 2005; Australian Commission on Safety and Quality in Healthcare 
2009) but the direct costs of care in general practice only averaged 5.5% of the total 
healthcare expenditure (Harris and Harris 2006; Australian Institute of Health and 
Welfare 2005a).  GPs also exercised a significant influence on pharmaceutical (24%), 
specialist care (10%) and hospitalisation (29%) expenses (Australian Institute of 
Health and Welfare 2005a).  In both a medical and social sense, general practice 
plays an important role in determining health and health inequalities (Furler 2006; 
Furler and Palmer 2010). Evidence has suggested that increasing the number of GPs 
actually increases overall quality of care as compared to increasing the number of 
other medical specialists (Starfield 1994; Starfield and Shi 2002; Radford 2009; 
Royal Australian College of General Practitioners 2009a; Stange 2009; Scott 2009; 
Kringos et al. 2010).  However, there is also the contrary view that underemployed 
GPs can potentially ‘over-service’ patients (Weller and Maynard 2004; Wong, 
Bentzen, and Wang 2008). 
 
                                               
3 Also known as ‘family doctor’, ‘family physician’, ‘primary care doctor’ and ‘primary care 
physician’. 
4 Also known as ‘chemist’ or ‘druggist’. 
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Even though the core concept of primary care and the GP is generally not well 
appreciated nor understood by the public (Stange 2009), the role of the GP is often 
perceived to be the team leader or coordinator of patient care (Light 2005a; 
Fitzgerald 2006; Royal Australian College of General Practitioners 2005).  He/she 
works collaboratively with other health professionals, not in competition 
(Thistlethwaite and Topps 2009; Fitzgerald 2006; Carnell 2006; Kringos et al. 2010), 
to provide accessible and comprehensive care for common problems and continuity 
of care (Wearne 2009; Fitzgerald 2006; Dowrick 2006; Royal Australian College of 
General Practitioners 2005; Gunn et al. 2008; Kringos et al. 2010), and early 
detection of chronic disease and disease prevention (Dowrick 2006; Van Der 
Weyden 2005; Carnell 2006; Kringos et al. 2010).  
 
An important strength of GP care is his/ her ability to flexibly tailor and integrate 
different aspects of care, adopting a whole person multi-system approach (Gunn 
2009; Kringos et al. 2010).  A GP is able to take a broad view of a patient’s needs 
and yet be able to selectively narrow and prioritize care, thus moving beyond a 
disease-by-disease approach but rather specialising in the care as a whole of the 
person they are treating (Radford 2009; Stange 2009). 
 
3.1.1. General Practitioner and Rural Health 
 
More than one-third of the Australian population resides outside major cities 
(Wakerman et al. 2008; Hugo 2005; Wakerman et al. 2009; Strasser 2000; Fatovich 
2009; Western et al. 2000; Phillips 2009; Dunbar and Reddy 2009), but only 17% of 
the GP population is based in rural and remote Australia (Britt, Miller, Charles, 
Henderson et al. 2008; Australian Bureau of Statistics 2002; Towler 2007).  Other 
than the maldistribution of GPs, the GP-utilisation rate per head of population is 
lower in rural areas (3.2 - 3.6 in remote vs. 5.2 - 5.7 in urban areas) (O'Halloran et al. 
2003; Beilby and Furler 2004; Britt, Miller, Charles, Bayram et al. 2008; General 
Practice in Australia, Health Priorities and Policies 1998 to 2008  2009).  The 
reported level of less frequent annual visits per patient suggests that there is less 





The notion of inverse care, where people most in need of healthcare are frequently 
least likely to receive it (Hart 1971), is ever more evident in rural Australia where 
there is an ever increasing health inequality between urban and rural dwellers in 
regard to health and access to health services (Maxwell 2006; Wakerman et al. 2008; 
Strasser 2000; Hugo 2005; Newman, Baum, and Harris 2006; Commonwealth 
Department of Health and Ageing 2009b; Dunbar and Reddy 2009; Wakerman and 
Humphreys 2002).  For instance, there is a higher proportion of indigenous 
Australians living outside of metropolitan areas and a higher proportion of Medicare 
concessional card holders and higher levels of unemployment.  Rural residents as 
compared to their urban counterparts, tend to: 
• be older,  
• have shorter life expectancy,  
• a higher morbidity and mortality rate, 
• be more likely to have a disability or be chronically ill, and 
• be more likely to place themselves at higher risk of poor health, including 
because of smoking, being overweight and having excessive alcohol 
consumption 
(Phillips 2005; Newton et al. 2007; Wearne and Wakerman 2004; Simpson 2006; 
Knox et al. 2005; Hugo 2005; Ball 2007, 2009; Strasser 2000; Bayram et al. 2007; 
Smith et al. 2008; Smith, Humphreys, and Wilson 2008; Australian Institute of 
Health and Welfare 2005b; Lavelle 2003; Wakerman and Humphreys 2002).  
 
Rural residents are less inclined to seek health services (Australian Institute of Health 
and Welfare 2005b; Phillips 2009; Wong and Regan 2009; Beard et al. 2009; Dunbar 
and Reddy 2009), probably due to greater difficulties in accessing health services: 
road travel distances and speeds on them are greater, and road conditions are 
arguably worse (Phillips 2009; Greenhill, Mildenhall, and Rosenthal 2008; Hugo 
2005; Smith 2010).  This is despite recent advances in technology (Gregory 2009).  
Consequently trauma and road accidents contribute to higher mortality due to 
distances from healthcare facilities (Reavy 2009; Fatovich 2009).   
 
In addition, the mean weekly family income is lower (AUD$700 - AUD$799 in rural 
vs. AUD$1,000 - AUD$1,199 in urban) (Hugo 2005) but the costs of health services 
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are higher (Rural Doctors Association of Australia 2005; National Rural Health 
Alliance 2008b; Wakerman et al. 2008; Zhao and Malyon 2010).   
 
Rural health services are characterised by multiple and fragmented funding streams 
(Commonwealth Department of Health and Ageing 2009b) and service delivery 
arrangements are inflexible and poorly coordinated (Commonwealth Department of 
Health and Ageing 2009b; Wakerman et al. 2008).   
 
Workforce shortages exist across most primary health care professions and are 
exacerbated by maldistribution (Gorman and Brooks 2009; Scott 2009; Sims and 
Bolton 2004; Wilson et al. 2009; Wilson, Oldenburg, and Lopez 2003; O'Toole, 
Schoo, and Hernan 2010; Wibowo 2007). 
 
These self-perpetuated issues maintain the vicious cycle of health inequality in rural 
Australia. 
 
3.1.2. Rural Index 
 
There is no Australian definition of ‘rural’ (Fatovich 2009) but arguably there are 
two distinct elements to the term ‘rural’.  One is the concept of ‘rural’ as distinct 
from ‘metropolitan’, which has predominately been addressed by distinguishing 
between city and country, and focusing on a normative construct that constitutes ‘city’ 
through criteria such as population numbers (McGrail et al. 2005).  The other 
concept is of accessibility to services and remoteness (Fantus and Foley 2008).  
There is no essential rural or metropolitan, but rather a continuum based on 
population numbers, accessibility of services, and attitudes or values. (McGrail et al. 
2005). 
 
In Australia, several different indexes of rurality are used as proxy measurements. 
These indexes include the Rural, Remote and Metropolitan Area (RRMA) 
classification which was first developed in 1991.  The RRMA categorises areas into 
one of seven levels, mostly based on population size. It is widely used by 





The Accessibility and Remoteness Index of Australia (ARIA) was developed in 1997 
as a strictly geographic measurement of remoteness from goods and services. Rather 
than the population size that the RRMA is based on, ARIA uses road distance from 
four levels of neighbouring service centres to calculate a remoteness score which is 
then categorised into five levels of remoteness (Knox et al. 2005). 
 
The Australian Standard Geographical Classification (ASGC) Remoteness Structure 
with five ordinal remoteness categories was released in 2001 (Australian Bureau of 
Statistics 2003).  As compared to the ARIA, the ASGC uses distance from five rather 
than four classes of service centres. 
 
Despite the simplicity of use, a key disadvantage of using any of the rurality indexes 
is that populations of most rural communities are not homogenous; either within or 
among communities (Hugo 2005) and that requirements of rural and remote 
communities are diverse (Ball 2006).  None of the existing rurality classifications 
were designed specifically to guide health resource allocation, and all exhibit strong 
weaknesses when applied for this purpose (McGrail and Humphreys 2009a; Dugdale 
2007).  In addition, there is no ‘one size fits all’ health service model (National Rural 
Health Alliance 2008b; Alfred, Kalucy, and McIntyre 2008; Bracey 2008).  Often, 
rural and remote communities are too small to support traditional models of health 
delivery locally so residents have to access health care from larger regional towns or 
even from urban centres which are generally able to support a wider range of health 
services (Wakerman et al. 2008).  It has been estimated that the critical minimum 
population base of 5,000 inhabitants for rural areas and 2,000 - 3,000 people for 
remote communities is necessary to support a comprehensive and sustainable range 
of primary health care services (Wakerman et al. 2005; Wakerman et al. 2008; 
Wakerman et al. 2009; Berbatis et al. 2007; Wibowo 2007).  
 
Whilst remoteness may play a major role in determining the health outcomes, nature 
and level of access and provision of health services (Phillips 2009; Dunbar and 
Reddy 2009), rurality by itself does not always translate into health disadvantage 
(Smith, Humphreys, and Wilson 2008); rather, it has been argued that rurality 
exacerbates the negative effects of remoteness such as socio-economic disadvantage, 
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ethnicity, poorer service availability and higher personal risk.  For instance, evidence 
from past economic crises has demonstrated that the worst health outcomes were 
observed in mining towns and rural areas where drought had already taken its toll 
(McCredie 2009; Ostry 2009; Reavy 2009); consequently, residents were forced to 
choose between buying much-need medications and shoes for children against high 
petrol prices, raising household costs, as well as the increased co-payments for 
medicines and safety net threshold for the PBS.  The Medical Observer annual 
survey found that 83% of GPs had seen patients refuse optimal treatment because of 
costs (Fleming 2006).  A recent qualitative study also found that lack of flexibility in 
rural health care services delivery influenced whether patients experienced economic 
hardship (Jeon et al. 2009) since social determination of health and primary 
healthcare services are not mutually exclusive (Rasanathan et al. 2009).  This 
suggested that what is needed in rural Australia is a flexible healthcare service model 
(Rural Pharmacy workforce Program 2009; Emerson, Bell, and Croucher 2001; 
Bracey 2008; National Rural Health Alliance 2008c, 2008b, 2008a; Alfred, Kalucy, 
and McIntyre 2008; O'Toole, Schoo, and Hernan 2010). 
 
Rural GPs, with their traditional involvement in ‘cradle-to-grave’ activities, have 
assumed the role of healer, carer, counsellor and friend in many country communities 
where they practice (Humphreys, Mathews-Cowey, and Weinand 1997; Page 2005).  
However, with the uneven distribution of higher morbidity and mortality in rural 
Australia, the clinical workload of a rural GP is more complex than that of his/her 
urban counterpart (Wearne and Wakerman 2004; Western et al. 2000; Britt et al. 
2009), requiring “a higher level of clinical acumen to diagnose and manage illness, 
as there are often no pathology, radiology or other usual clinical diagnostic support 
and specialist services, and the ultimate responsibility lies with the remote doctors” 
(Smith et al. 2008)(p159).  
 
Consequently rural GPs work longer hours (Phillips 2005; Schofield et al. 2006; 
Holden 1990; Western et al. 2000; Britt et al. 2009; Humphreys et al. 2002), have 
heavier clinical loads (Knox et al. 2005; Western et al. 2000; Ashworth and 
Armstrong 2006), but receive lower incomes (Kamien 2004; Page 2005).  Other 
barriers that rural GPs face include: greater involvement in all aspects of patient 
treatment in the absence of other medical specialists, personal and professional 
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isolation, lack of access to educational opportunities, and difficulty in getting a 
locum (Page 2005; Playford, Larson, and Wheatland 2006; Lavelle 2003; Coote 2009; 
Knox et al. 2005; Western et al. 2000; Humphreys et al. 2002).   
 
These factors could explain the high turnover of GPs reported across rural and 
remote Australia (Schofield et al. 2006; Bayram et al. 2007; Eley and Young 2008; 
Western et al. 2000).  The higher turnover of GPs and higher proportion of retiring 
GPs in rural communities (average 51 years old in rural vs. 49 years old in urban) has 
created difficulties in maintaining a continuous relationship that is vital for primary 
care, especially so for those needing continuous management for their chronic 
conditions (Wong and Regan 2009; Britt et al. 2009; Carnell 2006).  
 
3.1.3. International Medical Graduates 
 
The medical workforce shortage has reached critical levels in rural and remote 
Australia (Arnold 2005; Bracey 2008; Avon Valley Advocate 2009).  Incentives to 
lure doctors to rural Australia include increased rural GP training places, compulsory 
GP-registrar training deployment to rural general practices, retention payments for 
rural GPs, higher MBS rebates, rural scholarships for undergraduate medical degrees, 
and recruitment of international medical graduates5
 
 (IMGs) (Lokuge, Denniss, and 
Faunce 2005; Wearne 2009; Wearne and Wakerman 2004; Elliot et al. 2009). 
Many of the rural communities now depend on salaried practice arrangements or 
IMGs practising on restricted provider numbers to meet their communities’ primary 
care needs (Jones, Humphreys, and Adena 2004; Overs 2008; McNutty 2008; 
Bayram et al. 2007; Naccarella, Buchan, and Brooks 2010; Gorman and Brooks 2009; 
Joyce 2004).  Currently about 40 - 50% of rural GPs have graduated overseas 
(Maxfield 2009; Gregory 2009; Joyce 2004), mostly in South Africa and India 
(Birrell 2004; Western Australian Centre for Remote and Rural Medicine 2005). 
 
The Commonwealth Government’s policy of compulsory rural IMG placement has 
failed to build a permanent skilled rural medical workforce (Maxfield 2009) but this 
                                               
5 Also referred to in the literature as ‘overseas-trained doctors’. 
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short-term solution of recruiting foreign doctors from countries that experience a dire 
shortage of doctors themselves and where such doctors are arguably much more 
needed, and forced rural deployment have raised an ethical dilemma (Rosenberg 
2008; Maxfield 2009; Wilson et al. 2009; Levy 2010).  Nevertheless, it appears that 
the Australian rural health medical workforce is likely to be heavily dependent on 
IMG for some time to come (Van Der Weyden and Chew 2004; Bayram et al. 2007) 
since it takes nearly 10 years of intensive study to become a GP (Saratchandran 
2005). 
 
IMGs are a very diverse group with variable needs for training and up-skilling 
(Alexander and Fraser 2007). Some commentators have argued that the background 
training, communication skills, clinical skills and orientation to the Australian 
healthcare system can vary markedly among IMGs hence the government policy of 
placing IMGs in rural and remote Australia may actually compromise patient safety 
(McGrath 2004).  The current process of placing IMGs directly into areas of unmet 
need positions or districts of workforce shortage has meant that there is virtually no 
funding for pre-employment assessment, support, training and appropriate 
supervision (McGrath 2004).  In addition, IMGs also have reported significant 
discrimination from both the medical fraternity and the communities which they 
themselves have serviced (McNutty 2008; McKenzie 2010b; Wilson 2010b, 2010a).  
 
3.2. Roles of Community Pharmacists in Australia Healthcare 
 
There are some 4,800 community pharmacies in Australia (Williams 2004), and they 
serve an important link between doctors and patients. The shop-front feature of 
community pharmacy presents itself as a convenient first point of contact for patients 
without a formal appointment (Selya 1998; Hittner 1996; Benrimoj and Frommer 
2004; Sunderland et al. 2006; Australian Journal of Pharmacy 2007b; McIntosh and 
Kiernan 2008; Barber 2009; Roughead, Semple, and Vitry 2004).  Pharmacists have 
been continuously ranked highly on most trusted professionals surveys (Eaton 2005; 
Strasser 2000).  
 
The dispensing of PBS pharmaceutical benefits may represent up to 75% of a 
community pharmacy’s business (Casey, Klinger, and Moscovice 2002; Gottliebsen 
53 
 
2004; Williams 2004; Berbatis et al. 2007; Wibowo 2007; Gadiel 2008), but with the 
falling PBS profit margin in recent years pharmacists have been urged to move 
beyond reliance on PBS alone and see themselves as valued health professionals 
(Grogan 2007; Doyle 2009b; Annabel 2006; Australian Journal of Pharmacy 2005c; 
van Grootheest and de Jong-van den Berg 2005; Cipolle, Strand, and Morley 1998; 
Annabel 2007; Tatchell 2006; Australian Journal of Pharmacy 2005d, 2006a). 
 
Pharmacists by virtue of their five years of training in areas such as clinical chemistry, 
pharmaceutics, therapeutics, pathophysiology, clinical pharmacology and principles 
of pharmaceutical care are equipped to complement doctors in a wide range of 
pharmaceutical care roles (Annabel 2006; Doyle 2009a; Cipolle, Strand, and Morley 
1998).  Pharmacists are ideally placed as consultant on pharmacotherapy offering 
medication risk-management functions for the individual patient (Grogan 2005; van 
Grootheest and de Jong-van den Berg 2005; Roberts and Stokes 1998; Doucette, 
Nevins, and McDonough 2005; Muller and McDanel 2006; Sclavos 2006).  Many 
out-patients often only visit one community pharmacy (Sunderland et al. 2006; 
Australian Journal of Pharmacy 2007b; Doucette, Nevins, and McDonough 2005) so 
that pharmacists are best suited to identify patients with risk factors for disease 
prevention (Grogan 2006; Martin 2005, 2007; Sunderland et al. 2006; Joyce et al. 
2007; Berbatis and Sunderland 2008) and to serve as a conduit between the doctor 
and the patient (Bracey 2007a; Roberts 2006; Parker 2005; Doucette, Nevins, and 
McDonough 2005; Muller and McDanel 2006). 
 
However, pharmaceutical care and dispensing of pharmaceutical products are two 
very different activities (Cipolle, Strand, and Morley 1998).  There are inherent 
tensions in the role of a community pharmacist as both a private retailer and a health 
professional (Taylor, Mrazek, and Mossialos 2004) such as in the potential conflict of 
interest when prescribing and dispensing (Keddie 2003; Williams 2004; Smith 2007). 
 
Gadiel (2008) who contributed towards the Pharmacy Guild of Australia (the “Guild”) 
cost-benefit study on S2 and S3 pharmaceuticals6
                                               
6 S2 and S3 refer to Schedules 2 and 3 of the Standard for the Uniform Scheduling of Drugs and 
Poisons.  This document is produced by the National Drugs and Poisons Scheduling Committee, a 
 commented that, the protectionist-
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style regulatory framework currently in place to govern the community pharmacy 
industry resulted in Australia’s most protect industries.  It was argued that whilst 
there are benefits in regulating pharmacy quality standards, there can be none for 
restricting entry and ownership of community pharmacy:  
“the welfare loss from restrictions on where consumers may shop, the 
inflated prices they consequently pay, and the inefficient use of labour 
and capital associated with local or quasi-monopoly profits are likely to 
be a considerable economic burden.” (Gadiel 2008)(p3). 
 
3.2.1. Pharmacy Guild of Australia 
 
The Guild was established to represent all the community pharmacy owners in 
Australia (Emerson, Bell, and Croucher 2001; Keddie 2003; Royal Australian 
College of General Practitioners 2009c).  Non-pharmacy owners and pharmacy 
owners can hold membership of other pharmacist professional bodies such as the 
Pharmaceutical Society of Australia and/or the Australian College of Accreditated 
Pharmacy [sic]. 
 
The Guild is a very powerful political lobbyist and has successfully negotiated with 
successive Commonwealth Governments on a series of Community Pharmacy 
Agreements.  The Guild offers a powerful political bargaining chip in dealing with 
governments by influencing what is dispensed or bought by patients (Maher 2004; 
Roberts 2006; Eton 2007b; Sanofi-Aventis Australia 2007).  The negotiated terms 
contained in the Community Pharmacy Agreements over prices, protection of 
pharmacy ownership, and infrastructure support have given pharmacy owners a 
collective advantage that doctor groups do not get because of their diverse 
representation (Keddie 2003; Burge 2005c; Moxham 2005; Coote 2009; Van Der 
Weyden 2009). 
 
Pursuant to the Community Pharmacy Agreements, the number of rural community 
pharmacies has increased (Pharmacy Review 2003; Tatchell 2005). 
                                                                                                                                     
committee of the Therapeutic Goods Administration.  The document is used in the regulation of drugs 




3.3. Doctor-Pharmacist Relationships 
 
Until recently, there have been significant tensions between doctors and pharmacists 
in Australia (Kernick 1997; Edmunds and Calnan 2001; Royal Australian College of 
General Practitioners 2009c).  
 
Pharmacists have blamed GPs for the PBS blow-out and inappropriate prescribing 
(Australian Medical Association 2006) and have pushed to be given more 
professional rights such as the ability to perform basic medical services like 
immunisation (Maher 2004) and prescribing of PBS items (Clements 2005b; Low 
2005; Australian Journal of Pharmacy 2006b; Vitry et al. 2006; Low 2007). 
 
In retaliation, doctors have accused pharmacists of wanting to become ‘super 
pharmacies with medical services’ (Clements 2005a; McCrory 2005).  Under 
amended legislation because of the Community Pharmacy Agreements, pharmacists 
can now own medical practices but not vice versa (Glasson 2004).  Many doctors 
still perceive the pharmacist’s role to be dispensing of pharmaceuticals, checking 
prescriptions, and providing compliance instructions and drug information to patients 
(Matsumoto, Shimizu, and Fukuoka 2003).  As commentators have said,  
“Whereas in the past pharmacists enjoyed a high status because of their 
understanding of an exclusive field of knowledge, it is now thought that 
they have become overqualified for their roles and ‘over-educated’ 
distributors of medicines. … [This led to the] political struggle to attain 
and maintain control and autonomy in a specific field and to protect 
territory in the labour market in order to secure higher income and more 
control over working conditions.” (Edmunds and Calnan 2001)(p944).  
According to a Medical Observer survey more than half the GPs surveyed stated that 
a greater role for pharmacists in patient care was inappropriate (Light 2005a). 
 
Despite the tension between the two professions, both doctors and pharmacists are 
important stakeholders in the Australia healthcare system (Rural Doctors Association 
of Australia 2006).  It has been acknowledged that further emphasis on differences 
56 
 
between those who make up the healthcare team would only damage collective 
efforts to create a continually improving healthcare system whilst recognition, 
mutual respect, and an appreciation of the constant redefinition of boundaries among 
the two professions are the key to a healthy healthcare system (Royal College of 








The aim of the ADD Study is to compare the PBS prescribing habits of Australian 
DDs with non-DDs.  However, the evaluation of the appropriateness of prescribing is 
a complex issue.  As indicated above, international studies on the prescribing of DDs 
have mostly focused on costs and volume.  The meta-analysis in Chapter II was 
limited by lower levels of good quality papers and was based across different 
healthcare systems.  The purpose of this chapter is to outline the methodological 
approach utilised for the ADD Study, how this study intended to build on what was 
already known about the topic of doctor dispensing and to contextualise it into the 
Australia context.  It presents the ADD Study protocol and the methodology for the 
first phase (quantitative) of the study.  The methodology for the second phase 
(qualitative) of the study is presented in Chapter VI. 
 
1. CHRONOLOGICAL SEQUENCE OF EVENTS 
 
This study first started as a stakeholder study on Australian DDs (February 2003 to 
March 2004) funded by the Rural Alliance of Chief Executives (Lim, Gray, and 
Roach 2004).  The report was subsequently used by the Australian College of Rural 
and Remote Medicine (ACRRM) and Rural Doctors Association of Australia 
(RDAA) in a joint submission to the Department during the Fourth Community 
Pharmacy Agreement between the Commonwealth Government and the Guild. 
 
Subsequently a parliamentary paper was prepared (June to August 2005) for the 
Federal Minister for Health and Ageing in regard to the automatic disqualification of 
a DD’s dispensing licence should a community pharmacy open up in a DD’s 
catchment (Lim and Russell 2005). 
 
Independently, one of the ADD Study investigators, Sunderland received a grant 
from the Guild in 2003 to conduct a comparative evaluation of pharmacy services in 





Through the earlier studies, several key stakeholders were identified.  They were: 
• Medical practitioners and medical profession organisations 
o DDs 
o Non-DDs 
o Australian Medical Association 
o ACRRM 
o RDAA 
o Royal Australian College of General Practitioners (RACGP) 
• Pharmacists and pharmacist profession organisations 
o Community pharmacists 
o Guild 
o Pharmaceutical Society of Australia 
• Health services providers 
o Nurses 
o Hospital pharmacists 
o Other rural and remote primary healthcare providers 
o Health Department, State Governments 
• Policy makers and advisory 
o Divisions of General Practice and other primary healthcare support 
organisations 
o National Prescribing Service (NPS) 
o Health Department, State Governments 
o Department of Health and Ageing, Commonwealth Government of 
Australia 
• Consumers/ Patients 
 
Unanimously, stakeholders identified the need for a better summative evaluation of 
DD’s practices in Australia.  Several research questions were identified which 
included: 
• Who are the DDs? 
• Are there any differences between the quality of DDs’ prescribing and dispensing? 
• How effective is the DD care model? 
• What influences DDs’ prescribing and dispensing? 
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• Where do DDs source their information? 
• Why do DDs dispense? 
 
Since November 2004 preliminary talks have been held with the Drug Utilisation 
Sub-Committee of the Pharmaceutical Benefits Advisory Committee in regard to 
technical feasibility in conducting such summative evaluation of DD practices. 
 
The formal negotiation with the Department commenced in August 2006 with 
representatives from: 
• Pharmaceutical Access and Quality Branch,  
• Pharmaceutical Benefits Branch,  
• Pharmaceutical Policy and Analysis Branch, and  
• Legal, Privacy and Information Services Branch. 
 
After a significant delay, consequent upon the change of Commonwealth 
Government in 2007, the final release of the aggregated de-indentified data were 
secured in October 2008. 
 
It was identified earlier that due to the political sensitivity of the research topic, 
funding from mainstream political lobbying organisations such as the Guild or 
Australian Medical Association would be inappropriate.  Consequently the ADD 
Study was taken up as a student project.  A research development grant was received 
from Primary Health Care Research, Evaluation and Development in 2007 for a 
period of 12 months.  An Australian Postgraduate Award and a Curtin Research top-
up Scholarship were also received for the study period January 2008 – April 2010.  
No other research funding was received for this study. 
 
2. METHODOLOGICAL DILEMMA 
 
As outlined in the background chapter (Chapter III), tension exists between 
pharmacist and doctor groups in Australia.  It was understood at the onset of this 
ADD Study that findings from the study would not necessarily be welcomed by 
either group and would be subjected to extensive scrutiny, especially should the 
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findings not conform with expectations from either group.  Consequently the 
methodology employed for the ADD Study would have to be credible, dependable 
and replicable.  In addition, coupled with the technical difficulty and practicality of 
this study, the methodology framework proposed would have to be flexible and 
inclusive.  
 
The research aim was clear but the research objectives to be addressed by the ADD 
Study would need to: 
• Firstly, include the interests and concerns of the key stakeholder groups; 
• Secondly, address the QUOROM statement (Moher et al. 2000) directly, 
especially with regards to transparency and acknowledge biases in its proposed 
methodology, since the systematic review above (Chapter II) revealed a lack of 
good SIGN quality papers; 
• Thirdly, include different sources and types of information to adequately inform 
policy (Lavis 2009), since the ADD Study is fundamentally a legislative 
evaluation of the Commonwealth Government policy to allow doctors to 
dispense PBS pharmaceutical benefits; and 
• Fourthly, be able to compare with overseas studies on DDs, with respect to the 
Australian data generated, as well as incorporate what has already been done on 
this topic in Australia. 
 
There existed significant practical and technical difficulties with regard to the above 
considerations.  For instance, stakeholder analysis may be the methodology of choice 
for analysing the interests and role of key players in a specific policy domain 
(Ranson and Bennett 2009), and can constitute broad groups: visible or hidden, 
active or passive, internal or external (Mehrizi, Ghasemzadeh, and Molas-Gallart 
2009).  However, stakeholder methods are often applied as a static framework and 
are unable to analyse changes in the policy process (Mehrizi, Ghasemzadeh, and 
Molas-Gallart 2009; Brugha and Varvasovszky 2000), and they are plagued by the 
time-dimension context (Brugha and Varvasovszky 2000; Ranson and Bennett 2009) 
and by stakeholder groups’ self-interest (Hasman 2003; Ranson and Bennett 2009).  
DDs are a minor group in Australia, unrepresented by mainstream political lobbyists, 
and are often shunned by both pharmacists and non-DDs, mainly because of their 
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role in dispensing for profit.  Should the ADD Study adopt a strict stakeholder 
methodology, the voices of DDs would mostly likely be silenced and arguably 
further marginalised. 
 
Practically, a consent-driven quantitative comparative study between DDs and 
matched non-DDs is likely to result in a study beset by lower statistical power 
because of the low number of DDs practising in Australia, as well as the commonly 
known fact that doctors are notoriously difficult to collect survey data from: 
averaging only a 57.5% response rate despite various reinforcement strategies (Cook, 
Dickinson, and Eccles 2009; Converse et al. 2008).  There also exists the highly 
probable selection bias of self-selecting DDs who are arguably better prescribers.  
Alternatively, a covert-type study methodology of recruiting participants but not 
informing them of the true purpose of the study, such as that utilised in the 
Zimbabwe study on DDs (Trap 2001; Trap and Hansen 2002a; Trap and Hansen 
2002b; Trap, Hansen, and Hogerzeil 2002) is unlikely to be approved by any human 
research ethic committees in Australia. 
 
Technically, the PBS and MBS data are managed by Medicare Australia.  Release of 
data is subjected to strict secrecy7 and privacy8
• Will it support health professionals in their clinical practice? 
 legislative protection (Legal Privacy 
and Information Services Branch 2005).  The request for Medicare data is subjected 
to lengthy administrative protocols and justification of public interest test: 
• Will it support health care consumers to make more informed choices about their 
health care? 
• Will it support stakeholders in the health industry to develop and monitor 
initiatives aimed at improving Australia’s health? 
• Will it support partnerships within the health sector? 
• Will it support initiatives aimed at increasing the knowledge base of Australia’s 
health sector, and sharing that knowledge within relevant parts of the sector? 
(Legal Privacy and Information Services Branch 2005). 
                                               
7 National Health Act 1935 (Cth) sections 135A and 135AAA. 
8 National Health Act 1935 (Cth) sections 135A and 135AA, Health Insurance Act 1973 (Cth) section 




Additionally, the Department could often reject requests on the basis of “insufficient 
resources to commit to your request at this time” (Holman 2008).  This in itself is not 
judicially reviewable under sections 24(1) and/or 41of the Freedom of Information 
Act 1982 (Cth). 
 
Even if Medicare data are to be released, it is further subjected to what the 
Department or Medicare Australia can and choose to provide, and further subject to 
cost of data retrieval and administration.  
 
Consequently it was identified early on, after stakeholder consultation, that any 
further project on DDs would need to be conducted as a student project.  Being a 
student project, the methodology should ideally be relatively straight-forward and 
manageable within the usual three-year timeframe.  Any findings from such 
proposed study would likely be heavily scrutinized because of their political 
implications, so that a popular methodology which is credible and easily 
understandable would need to be utilised.  Also, rather than formulating new 
variables to be tested, consideration needs to be given to what has already been done 
so as to minimise the need to justify the variables chosen. 
 
3. ADD STUDY PROTOCOL 
 
To understand whether DD’s ability to dispense PBS pharmaceutical benefits relates 
to their prescribing, the ADD Study aims to answer the following research questions: 
• What differences currently exist between the prescribing of DDs and non-DDs? 
• How does dispensing impact on DDs prescribing? 
 
The ADD Study elected to use sequential explanatory mixed methods (QUANqual) 
design.  The QUANqual methodological design is relevant because of its 
straightforwardness and manageability, since data were only collected as needed and 
in two distinct phases (Creswell 2009; Tashakkori and Teddlie 1998).  The 
QUANqual strategy offers opportunities for the exploration of the quantitative 
results in more detail through the qualitative phase, especially if unexpected results 
arise from the earlier quantitative study (Ivankova, Creswell, and Stick 2006; 
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Tashakkori and Teddlie 1998).  The theoretical perspective for QUANqual can be 
implicit (Kushman 1992; Creswell 2009); this design can therefore provide more 
defensible understanding of findings, with stronger validity, credibility and less 
known bias (Caracelli and Greene 1993; Giacomini and Cook 2000).  QUANqual 
design has previously been undertaken successfully in health and policy research 
(O'Cathain, Murphy, and Nicholl 2007; Zanberg and Berkowitz 2009; Warner 2009; 
Pearson and Godby 2009; Schattner et al. 2009; Stoller et al. 2009; Nastasi et al. 
2007), and a mixed methods approach inherently lends itself to legislative research 
(Lim and Lewis 2009; Plano Clark 2009) and to studies of vulnerable population and 
health disparities (Stewart et al. 2008; Christ 2007; Hodgkin 2008; Moffatt et al. 
2006).  The purpose of employing QUANqual design for ADD Study is the desire 
to survey a large sample of individual DDs then follow-up with a few of them to 
obtain their specific language and voices about the topic.  By collecting both closed-
ended quantitative data and open-ended qualitative data, answers to the study’s 
research question are capable of being generalised while also developing a detailed 
view of the meaning of the studied phenomenon (Creswell 2009).  This approach 
also aims to minimize any potential researcher bias with the interpretation of findings.  
However, limitations of employing QUANqual design in the ADD Study are: 
firstly the heavy reliance and dependence on release of PBS data by the Department; 
secondly, the longer time duration required to complete the research; and thirdly, 
there is a possibility that the two methods might yield heterogeneous results. 
 
During the study period, all the DDs in Australia were registered and practising as 
GPs hence for the purpose of the ADD Study, the term ‘DD’ was broadly defined as 
any GP who undertakes the role of dispensing PBS pharmaceutical benefits in 
situations that would normally be regarded as the practice of a community 
pharmacist. 
 
There were two phases to the ADD Study.  Phase I of the research consisted mainly 
of analysing quantitative data (PBS pharmaceutical benefits claimed data).  Phase II 
of the research involved collecting and analysing qualitative data (interviews with 
DDs) which would help to explain and elaborate on the quantitative results obtained 
in the first phase.  The second (qualitative) phase builds on the first (quantitative) 
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phase and the two phases are connected in both the intermediate stage and final stage 





Figure 4.1:  Visual model for sequential explanatory mixed methodology 




4. QUANTITATIVE METHODOLOGY 
 
The first phase of the study, as reported here, comprised a retrospective drug 
utilisation study with an emphasis on evaluating aspects of prescribing standards.  
Ethics approval was obtained from the Curtin University Human Research Ethics 






• Ethics approval 
• Cross-sectional PBS data of DDs (test) and non-DDs (controls) 
• 2005-2007 fiscal years PBS claimed data 
• Data screening 
• Frequencies: descriptive statistics, missing data, linearity, homoscedastricity, normality 




• Purposefully selecting respondents and quantitative results 
• Develop interview questions: interview protocol, ethics approval 
Qualitative  
Data collection 
• Recruitment (Divisions of General Practice network) 
• Individual in-depth interviews 




• Coding and thematic analysis: codes and themes 
• NVivo qualitative software 
Integration of the 
QUANqual 
results 
• Interpretation and explanation of the quantitative and qualitative results: discussion, 
implications, future research 
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4.1. Data Source 
 
An extract of PBS claims data for the index period 1 July 2005 to 30 June 2007 was 
used for this study.  When a PBS-listed pharmaceutical benefit is dispensed and 
subsequently claimed for by the authorised pharmacist or DD from the Department, 
an electronic record is kept at the Department.  Each claim represents an episode of 
supply of a PBS pharmaceutical benefit (a ‘script’).  
 
The PBS claim data were extracted by the Department in accordance with the 
legislative secrecy and privacy provisions.  Data were extracted using the unique 
individual prescriber number.  The extracted data were de-identified by the 
Department so that reverse identification of any individual prescriber (doctor) was 
not possible.  The de-identified data were then pooled by the Department into two 
categories: ‘rural’ (prescribers in RRMA 4 and 5) and ‘remote’ (prescribers in 
RRMA 6 and 7) before being released for subsequent analysis.  
 
4.2. Statistical Analysis 
 
Sample size was calculated by Power and Sample Size Calculator software (version 
2.1.31, Vanderbilt University, Nashville, TN, USA) (Dupont and Plummer 1990).  
The primary outcome of the study was the number of PBS scripts per 1,000 patients.  
This was a census study of DDs who were in practice in the two fiscal years studied.  
Based on 72 DDs and 1,080 non-DDs, this study had a power of 100% to detect a 5% 
difference in the PBS prescribing data at a significance level of 0.010 (CI 99%).  
This calculation was based on two British studies which used administrative data 
from 59 DD practices vs. 49 non-DD practices (Baines, Tolley, and Whynes 1996; 
Morton-Jones and Pringle 1993b): mean difference of 1.23 - 1.80 (SD 0.42) items 
prescribed per patient. 
 
Data were analysed using SPSS for Windows software (version 17.0).  Syntax was 
utilised to manage the large dataset as described elsewhere (Kelman et al. 2007; 
Zhang et al. 2007).  The normality of all the numerical variables was examined by 
normality test, histograms and normal q-q plots, showing no severe skewness of 
these variables. The pre-determined outcome variables (indicators) were distilled 
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from the systematic review outlined above.  For the comparison of differences 
between volume and other outcome variables, a Student’s t-test was employed.  The 
methodology and statistical approach employed for this study was consistent with 
overseas studies on DDs’ prescribing (Lim et al. 2009).  All results were reported as 
statistically significant at 0.010 levels. 
 
4.3. Volume Indicators 
 
The purpose of the quantitative phase of the ADD Study was not to focus on 
inventing new measures of evaluating DD practices but rather on incorporating 
overseas methodology to enable comparison.  Therefore the volume indicators 
explored were: 
 
• Number of individual patients per doctor (prescriber) 
This was an indicator used in the Zimbabwe (Trap 2001) and UK studies 
(Dispensing Doctors' Association 2004; Tennant 2006b). 
 
• Proportion of concessional and over-65 years old patients per doctor 
These two indicators were used in the Zimbabwe (Trap 2001; Trap, Hansen, and 
Hogerzeil 2002) and UK studies (Morton-Jones and Pringle 1993a; Baines and 
Whynes 1997; Watkins et al. 2003). 
 
• Number of PBS scripts per doctor 
The script per doctor indicator was used in Zimbabwe (Trap, Hansen, and 
Hogerzeil 2002), Pakistan (Siddiqi et al. 2002; Nizami, Khan, and Bhutta 1996), 
Taiwan (Chou et al. 2003), UK (Ward 2004; Tennant 2006b; Morton-Jones and 
Pringle 1993a; Morton-Jones and Pringle 1993b; Whynes, Baines, and Tolley 
1995; Wilcock 2001) and Australia studies (Sunderland, Burrows, and Joyce 
2006; Sunderland, Burrows, and Joyce 2005). 
 
• Number of PBS scripts per 1,000 patient 
The scripts per patient indicator was used in Zimbabwe (Trap, Hansen, and 
Hogerzeil 2002) and UK studies (Morton-Jones and Pringle 1993b; Baines, 
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Tolley, and Whynes 1996; Wilcock 2001; Stewart-Brown et al. 1995; Ward 
2003). 
 
• Proportion of concessional scripts per 1,000 concessional patients 
It was reported in the Zimbabwe (Trap 2001; Trap, Hansen, and Hogerzeil 2002) 
and UK studies (Morton-Jones and Pringle 1993a; Baines and Whynes 1997; 
Watkins et al. 2003) that concessional status was associated with higher volume 
of prescribing by DDs. 
 
• Proportion of Reg24 scripts 
This unique Australian indicator was requested by the stakeholders during the 
consultation phase.  Reg24 is made pursuant to regulation 24 of the National 
Health (Pharmaceutical Benefits) Regulations 1960 (Cth) whereby a prescriber 
may direct the supply on a single occasion the maximum quantity of a 
pharmaceutical benefit (original and all repeats) prescribed.  These are counted as 
two scripts (one for the original script and one for all the repeat scripts) (Titulaer 
2010).  In the fiscal years studied, the number of authorised repeats varied from 
one to five, with most chronic medications having five repeats.  Under the 
legislation, Reg24 may only be authorised for: (i) treatment of chronic illness or 
where patients cannot gain reasonable access to a pharmacy; and (ii) great 
hardship in obtaining the required quantity.   
 
• Proportion of proton pump inhibitors (PPIs) prescribed 
This was a volume indicator used in South Korean (Lee and Malone 2003), South 
Africa (Truter, Wiseman, and Kotze 1995) and UK studies (Baines and Whynes 
1997; Wilcock 2001). 
 
4.4. Prescribing Indicators 
 
The following prescribing indicators were used to compare DDs with non-DDs: 
 
• Proportion of antibiotics prescribed per 1,000 scripts 
A common indicator used in South African (Truter, Wiseman, and Kotze 1995), 
Zimbabwe (Trap and Hansen 2002b; Trap, Hansen, and Hogerzeil 2002), 
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Pakistan (Siddiqi et al. 2002; Nizami, Khan, and Bhutta 1996), South Korean 
(Park et al. 2005) and UK studies (Whynes, Baines, and Tolley 1995).  A lower 
prescription rate of antibiotics is indicative of better quality use of medicines. 
 
• Proportion of penicillins and cephalosporins prescribed per 1,000 scripts 
The appropriateness of antibiotic prescribing was reported in both Zimbabwe 
(Trap and Hansen 2002a; Trap and Hansen 2002b) and South Korean studies 
(Park et al. 2005). 
 
• Proportion of analgesics per 1,000 scripts 
This indicator was used in South African studies (Truter, Wiseman, and Kotze 
1995; Truter and Kotze 1996). 
 
• Drug classes which are commonly implicated in medication adverse effects 
A number of potential adverse drug events indicators were explored in relation to 
the appropriateness and the prevention of adverse events since a factor often 
raised in the debate over doctor dispensing is the importance of the secondary 
check by a pharmacist.  The increased use of the following drug classes had been 
reported to be associated with high rate of medication misadventure: 
• Cardiovascular drugs (Wester et al. 2008; Australian Journal of Pharmacy 
2007a; Pirmohamed et al. 2004; Zhang et al. 2007; Trewin et al. 1996; 
Roughead, Barratt, and Gilbert 2004; O'Halloran et al. 2003; Howard et al. 
2007; Preen et al. 2008; Jenkins 2008; Truter, Wiseman, and Kotze 1995), 
• Hypoglycaemic agents (Australian Journal of Pharmacy 2007a; Brvar et al. 
2009), 
• Antidepressants (Wester et al. 2008; Australian Journal of Pharmacy 2007a; 
Jenkins 2008), 
• Analgesics (Wester et al. 2008; Australian Journal of Pharmacy 2007a; 
Pirmohamed et al. 2004; Zhang et al. 2007; Robertson et al. 2002; Howard et 
al. 2007; Jenkins 2008; Truter, Wiseman, and Kotze 1995; Pearson et al. 2009; 
Brvar et al. 2009; Dowden 2009), 
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• Respiratory drugs (Roughead, Barratt, and Gilbert 2004; Trewin et al. 1996; 
Whynes, Baines, and Tolley 1995; National Prescribing Services Ltd 2006; 
Robertson 2009; Robertson et al. 2002), 
• Fluoroquinolone antibiotics (Adverse Drug Reactions Advisory Committee 
2008; Robertson 2009). 
 
 








This chapter presents the quantitative findings from the analysis of PBS claims data 
for the 2005-7 fiscal years. 
 
1. PATIENT DATA 
 
The data reported are for dispensed prescriptions from rurality-matched 72 DDs and 
1,080 non-DDs that were submitted to the PBS for payment.  Each item represents a 
dispensing occasion of an original or repeat prescription.  The mean (±SD) data for 
patients per doctor and prescription items dispensed are presented in Table 5.1. 
 
DDs prescribed to significantly fewer patients than non-DDs’ (1,137 vs. 1,718, p = 
0.000).  The most tenable explanation is that there were smaller patient populations 
in DDs’ areas than non-DDs.  However, the proportions of concessional patients and 
patients aged over 65 years old were similar between DDs and non-DDs 
(concessional: 711 vs. 680, p = 0.076; >65yo: 285 vs. 293, p = 0.597). 
 
2. VOLUME INDICATORS 
 
In general, DDs prescribed fewer PBS items per doctor than non-DDs (aggregate: 
11,691 vs. 24,888, p = 0.000; rural: 11,338 vs. 26,147, p = 0.002).  However, it was 
noted that a statistically non-significance different occurred between DDs and non-
DDs in the remote cohort (12,045 vs. 23,629, p = 0.014). 
 
The fewer PBS scripts per doctor can be partially explained by the lower number of 
individual patients per doctor at DDs’ sites (aggregate: 1,137 vs. 1,718, p = 0.000; 
rural: 1,180 vs. 1,775, p = 0.000; remote: 1,094 vs. 1,662, p = 0.000). 
 
However, DDs also generally prescribed proportionally fewer PBS items per 1,000 
patients than non-DDs (aggregate: 9,452 vs. 15,057, p = 0.003; remote: 11,072 vs. 
15,233, p = 0.008).  Statistically a non-significant difference was noted in the rural 
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cohort (7,832 vs. 14,882, p = 0.048) due to the wide standard deviation among the 
rural DDs population (6,534 vs. 3,076). 
 
There were generally no statistically significant differences in the prescribing of PBS 
concessional items per 1,000 concessional patients between DDs and non-DDs 
(aggregate: 10,939 vs. 16,190, p = 0.111; remote: 7,077 vs. 12,983, p = 0.194).  A 
statistically significant difference in the rural cohort was noted, with rural DDs 
prescribing fewer concessional scripts per 1,000 concessional patients (14,801 [SD 
1,069] vs. 19,398 [SD 230], p = 0.005). 
 
These results are likely to be influenced by Reg24 use.  In the current study, DDs 
generally prescribed significantly more Reg24 PBS scripts per 1,000 scripts than 
non-DDs (aggregate: 314 vs. 67, p = 0.008; rural: 546 vs. 66, p = 0.001).  The 
findings are likely to be influenced by the substantial wide standard deviation in the 
pooled (265 vs. 4) and rural (148 vs. 3) cohorts.  The increased Reg24 use was not 
statistically significant in the remote cohort (81 vs. 67, p = 0.563) probably due to the 
somewhat narrower standard deviation among remote DDs population (54 vs. 4) as 
compared to the other cohorts.  
 
An arbitrary correction factor of four (maximum variation) was applied to the DDs’ 
data and the amended findings, as presented in Table 5.2, indicated that in general 
DDs prescribed similar number of items per doctor, but probably more scripts more 
scripts per 1,000 patients, and more concessional scripts per 1,000 concessional 
patients.  The latter findings were not echoed in the remote cohort. 
 
3. PRESCRIBING INDICATORS 
 
Table 5.3 summarises the prescribing indicators used in this study.  For the drug 
classes which were reportedly associated with more frequent errors in medication 
safety, there were no statistically differences observed between DDs and non-DDs 
prescribing of: 
• cardiovascular drugs:  β-blockers, antithrombotic agents, cardiac glycosides 
(digoxin), HMG Co-A reductase inhibitors (statins), and frusemide diuretics, 




• opiate analgesics, 
• glucocorticoid inhalants, 
• theophylline, 
• fluoroquinolone type antibiotics, or 
• PPIs. 
 
DDs tended to prescribe statistically significantly more non-steroidal anti-
inflammatory drugs (NSAIDs) (aggregate: 45.41 vs. 39.08 items per 1,000 scripts, p 
= 0.001) despite no statistical significant differences being observed in either of the 
rural (46.14 vs. 37.50 items per 1,000 scripts, p = 0.076) or remote (44.88 vs. 40.52 
items per 1,000 scripts, p = 0.185) cohorts. 
 
DDs in general prescribed more adrenergic inhalants than non-DDs (aggregate: 44.36 
vs. 40.44 items per 1,000 scripts, p = 0.010; rural: 44.22 vs. 37.69, p = 0.001).  There 
was no statistical significant difference noted in the remote cohort (45.00 vs. 42.96 
items per 1,000 scripts, p = 0.500). 
 
In terms of antibiotic prescribing, the overall antibiotics prescribing appeared 
comparable with the exception that DDs prescribed more penicillin-type antibiotics 
than non-DDs (aggregate: 33.39 vs. 23.47 items per 1,000 scripts, p = 0.000; rural: 
31.64 vs. 22.09, p = 0.002; remote: 35.66 vs. 24.72, p = 0.000). 
 
The current study was unable to apply any meaningful correction to the above 
prescribing indicators to correct for the higher Reg24 use among some DDs reported 
earlier.  Nevertheless, the antibiotic variables were considered less likely to be 
influenced by Reg24 and there was no substantial difference between DDs and non-
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Table 5.1:  PBS patients and scripts data (means) between DDs and non-DDs.  The asterisk (“*”) denotes statistically significant (p ≤ 0.010). 
 
 
 Aggregate Rural Remote 
DD Non-DD DD Non-DD DD Non-DD 
Scripts per doctor 26 375 31 558 36 100 33 050 15 948 29 962 
Scripts per 1,000 patients 21 324 19 092 24 937 18 811 14 659 19 315 
Concessional scripts per 1,000 concessional patients 24 678 20 529 47 126 24 519 9 370 16 462 
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Respiratory drugs: 
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(0.31, 19.40) 0.045 
Table 5.3:  Prescribing indicators (per 1,000 scripts) between DDs and non-DDs.  The asterisk (“*”) denotes statistically significant (p ≤ 0.010). 
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4. SENSITIVITY ANALYSIS 
 
Table 5.4 summarises the sensitivity analysis conducted to compare the main volume 
indicators across the two fiscal years so as to ensure the validity of the PBS data 
provided by the Department.  There were no significant statistical differences 
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Table 5.5 summarises the comparison between ADD Study data and Pharmaceutical 
Benefits Pricing Authority (PBPA) summary for the 2005-6 fiscal year based on the 
top five commonest drug classes (Pharmaceutical Benefits Pricing Authority 2006).  
With the exception of lower antibiotics use identified in this study, there does not 
appear to be much dissimilarity between the two data sources.  Statistical 
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comparisons between the PBPA and these data are not possible since PBPA data are 




Drug class ADD Study (%) PBPA (%) 
Statins 10.399 10.317 
PPIs 8.991 8.127 
Antibiotics 4.922 6.717 
Anti-diabetes agents 3.633 3.272 
Anti-thrombotic agents 3.305 3.268 
Table 5.5: Comparison of the ADD Study PBS data against Pharmaceutical 






In this innovative study on Australian DDs, DDs prescribed to fewer individual 
patients than non-DDs, and consequently there were fewer PBS scripts per doctor.  
The study findings are at variance with international data, where DDs were found to 
prescribe at higher rates.  The data were potentially biased by a higher Reg24 use 
among DDs.  In this study accurate correction factor to the script-denominator could 
not be applied due to the data format that was made available from the Department.  
Correction for Reg24 was not routinely performed by the Department due to the low 
frequency of its use nationally (Titulaer 2010).  Nevertheless, when the most 
stringent correction for Reg24 to the script-denominator was applied, it was found 
that marginally higher rates of prescribing by DDs could have occurred in the rural 
cohort.  The wider standard deviation observed among the rural DD cohort suggested 
that some DDs used Reg24 more frequently than other DDs.  Therefore, the actual 
prescribing rates may lie somewhere between those presented in Tables 5.1 and 5.2. 
 
In this study, DDs had a smaller patient population as compared to those of their 
non-dispensing peers.  With the similar proportion of concessional and over 65 years 
old patients, DDs may have fewer non-concessional (general category) patients per 
doctor than their rurality-matched non-dispensing peers.  It was reported previously 
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in the survey of seven WA DDs’ towns that 21.2% of respondents “never” attend 
their local DD’s medical practice (Sunderland, Burrows, and Joyce 2005)(p55).  In 
the same report, a significant proportion of spillage from DDs to pharmacists’ towns 
for their scripts to be filled was also noted (11.5% - 59.3%).  Therefore, a plausible 
explanation could be that non-concessional patients are more mobile and travel to 
larger regional towns for both their medical and pharmaceutical care.  This in turn 
may explain the increased Reg24 use among the DD cohorts: DDs’ patients have less 
ability to travel hence this justified the use of Reg24.  
 
The data captured and subsequently analysed above were based solely on PBS 
pharmaceuticals that were dispensed; they therefore do not include doctors’ 
prescriptions that were supplied to patients but which patients had opted not to fill at 
either a community pharmacy or a DDs’ dispensary.  Hence PBS claimed data are 
more accurately a measure of community drug utilisation and exposure rather than a 
prescriber’s prescribing frequency.  Nevertheless, a pilot study conducted of 25 GPs 
in rural WA, which compared a selected number of respiratory pharmaceutical items 
prescribed but not dispensed found, a spillage rate of some 5-10% (Lim and Rowett 
2006); this suggests that analysis of PBS utilisation data may have higher correlation 
to prescribing rates in country Australia than one might have otherwise expected. 
 
The PBS datasets do not capture the indication/s for use (Robertson et al. 2002; 
Legal Privacy and Information Services Branch 2005; Kelman et al. 2007) and the 
data were based on claims made against the PBS.  Therefore data for prescriptions 
that was for less than the cost of stipulated co-payments may not have been captured.  
This is especially an issue for the NSAID and antibiotic prescribing indicators since 
the majority of the antibiotic classes investigated fell below the general co-payment 
threshold (2005: AUD$28.60; 2006: AUD$29.50).  An earlier study by NPS claimed 
that only 56% of community antibiotics usage were successfully captured through 
the PBS (Wutzke et al. 2006).  Nevertheless, those prescribed to in the concessional 
category should be fully captured (2005: AUD$4.60; 2006: AUD$4.70). 
 
Similarly there was a potential bias in relation to capture of adrenergic inhalants data.  
In Australia, short-acting β2-adrenergic salbutamol inhalants can be dispensed by 
community pharmacists over the counter as a pharmacist-only medication (S3) 
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without the need for a doctor’s prescription therefore this is not captured by PBS.  
Alternatively, the doctors might prescribe the salbutamol inhalants as a PBS 
subsidised pharmaceutical benefit and the data is captured by the PBS.  There are 
differences between the dispensing of a salbutamol inhalant as a S3 medication or as 
a PBS pharmaceutical benefit.  For instance, in some states of Australia, DDs are not 
allowed to dispense over-the-counter medications and therefore DDs can only 
prescribe and dispense under the PBS.  This could potentially lead to bias and 
overestimation of rates of adrenergic inhalants and NSAIDs use by DDs as observed 
in this study.  
 
Despite limitations with administrative datasets, PBS claimed data remain an 
important source of information on drug utilisation since approximately 86% of all 
community pharmaceutical prescriptions in Australia are dispensed under this 
scheme (Wutzke et al. 2006).  Analyses of PBS datasets are used widely to evaluate 
trends and patterns of pharmaceutical use (Horn et al. 2006; Mandryk et al. 2006; 
Wutzke et al. 2006; Robertson et al. 2002; Lu, Williams, and O'Day 2006; Lynd et al. 
2002; Ampon et al. 2009) and as a basis for pharmacoeconomic analysis (Edmonds 
et al. 1993).  For the ADD Study the number of rurality-matched controls (non-DDs) 
was intentionally increased so as to enhance this study’s precision (Dhaliwal and 
Campbell 2010).  This was opted for as a trade-off against the inherent limitations 
with the PBS dataset.  No formal adjustment for statistical multiple testing was 
conducted since the predicted variables were pre-determined (that is informed by 
systematic review and stakeholder consultations).  Therefore the current study was 
performing multiple tests of specific hypotheses (performing single test of multiple 
hypotheses as compared to performing multiple tests of a single hypothesis) (Saville 
2003; Bender and Lange 2001; Strug and Hodge 2006; Perneger 1998; Bland and 
Altman 1995; Rothman 1990).  Methods to adjust for multiple testing may not 
further assist validity of the statistical inference.  This statistical approach was 
consistent with overseas studies on DDs (Lim et al. 2009). 
 
The PBS administrative data for the 2005 to 2007 fiscal years were chosen for three 
reasons.  Firstly, at the time of negotiation for release of data, these two fiscal years 
represented the most comprehensive data that was available at that time.  Secondly, 
the investigator was made aware that in the subsequent 2007-8 fiscal year; at least 
 79 
four DDs in WA had lost their PBS dispensing licence because of a new pharmacy 
opening up in the respective DD’s catchment, whereas between 2005 and 2007 there 
had been no change in the actual DD numbers.  Thirdly, the 2004-5 fiscal year data 
were not included as it is highly probable that the substantive 24% increase in patient 
co-payments in 2004 could have influenced PBS usage in that fiscal year (Hynd 2008; 
Hynd et al. 2008; Hynd et al. 2009).  Furthermore, sensitivity analyses of this study’s 
PBS data did not reveal substantive differences across the fiscal years under study or 
when measured against similar administrative data source. 
 
The current study did not find substantive differences in many aspects of prescribing 
between DDs and non-DDs.  This is in contrast to the systematic review which was 
based on overseas DDs who practised in somewhat different healthcare systems than 
is Australia.  However, further study into this topic is warranted to test the validity of 
these preliminary findings and explore factors that might explain the variability 





VI. CONNECTING THE QUANTITATIVE AND QUALITATIVE METHODS 
 
 
By virtue of the mixed methods definition, the integration 9
 
 of quantitative and 
qualitative methodology is a vital part of mixing the methods (Bazeley 2009; 
Creswell 2009; Bryman 2007; Teddlie and Yu 2007; Ivankova, Creswell, and Stick 
2006; Teddlie and Tashakkori 2009; Lingard, Albert, and Levinson 2008).  
Integration between quantitative and qualitative methods may entail selection of 
statistically significant (and non-significant) results (Ivankova, Creswell, and Stick 
2006; Creswell and Plano Clark 2009), development of interview question to focus 
on the significant (and non-significant) predictors (Creswell 2009), and/or selection 
of participants (Creswell 2009).  In this chapter, the qualitative methodology of the 
ADD study is presented. 
1. SELECTION OF QUANTITATIVE RESULTS FOR INTERVIEW QUESTIONS 
 
1.1. Accuracy of PBS Data 
 
There are inherent limitations with PBS administrative data, explanations offered by 
DDs would provide in-depth understanding of why and what influences their 
prescribing. 
 
The PBS data provided for the ADD Study were extracted and pooled into rural and 
remote.  Pooling of PBS data may decrease the sensitivity of analysis to detect small 
area variations such as differing levels of morbidity and access to services, and may 
disguise real differences e.g. between GP practices in coastal centres and inland rural 
towns (McGrail and Humphreys 2009b; Ferguson 2009) or if the GP is procedural or 
non-procedural (Ferguson 2009).  However, the analysis of data aggregated at the 
national level is a compromise: the coarser the level of analysis the less an individual 
doctor’s prescribing habits affect the overall picture (Wilcock 2001, 2002, 2003; 
Wilcock and Mackenzie 2000).  It was a fundamental assumption that patient 
demography would be similar in the same RRMA classification.  The original ADD 
                                               
9 The word “integration” is used generically rather than semantically as proposed by (Mason 2009). 
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Study protocol submitted to the Department for ethics and research considerations 
had initially asked for the DDs to be matched based on the ARIA which is arguably 
more sensitive because the ARIA takes account of availability of services in addition 
to patient population.  An assumption is that DDs’ towns are more isolated and have 
less access to essential services, and consequently more reliance on DDs’ services.  
This might explain the increased use of Reg24 by DDs.  Other explanations may 
exist and need to be explored. 
 
1.2. Disease State Management 
 
There were no statistically significant differences observed across many of the 
prescribing indicators.  The qualitative interview would provide an understanding 
from DDs where they sourced their knowledge of pharmaceuticals and pharmaco-
therapeutics, as well as unique factors that might influence their prescribing habits. 
 
1.3. Why Dispense 
 
A key consideration for incorporating the qualitative phase to the ADD Study was to 
ascertain why DDs choose to dispense.  There are strict administrative requirements 
for seeking the PBS dispensing licence by a medical practitioner, and there are also 
onerous administrative reporting requirements for making claims against the PBS.  It 
is of interest to the stakeholders why DDs have taken on this additional role, what 




The quantitative variables which would be explored in more details through the 
qualitative phase of the ADD Study are as follows: 
 
• How does the DD perceive his/her prescribing volume as compared to their non-
dispensing peers? 
o Scripts per doctor:  11,691 vs. 24,888 
o Scripts per 1,000 patients:  9,452 vs. 15,057 
o Patients per doctor:  1,137 vs. 1,718 
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• Why is there large variability in the rate of Reg24 use? When does a DD use 
Reg24? 
o Reg24 per 1,000 scripts:  314 vs. 67 
o Standard deviation of Reg24:  265 vs. 4 
 
• What influences a DD’s prescribing? Where or how does the DD source 
information? 
o NSAIDs per 1,000 scripts: 45.41 vs. 39.08 
o Adrenergic inhalants per 1,000 scripts: 44.6 vs. 40.44 
o Penicillin type antibiotics per 1,000 scripts 33.39 vs. 23.47 
o See also other non-statistically significant prescribing indicators in Table 5.3. 
 
• Why does a DD dispense? 
 
• What barriers and enablers are there to doctor dispensing? 
 
2. QUALITATIVE METHODOLOGY 
 
For this second phase of the ADD Study, separate ethics approval was granted by 
Curtin University Human Research Ethics Committee (SPH-0048-2008). 
 
2.1. Study Design 
 
An iterative, qualitative descriptive methodology as described elsewhere by 
Sandelowski (2000) was utilised.  The strength of qualitative methodology is that it 
provides thick description and understanding of complex human phenomena 
especially where subjectivity is involved and flexibility is required (Speziale and 
Carpenter 2003; Miles and Huberman 1994; Gobo 2005; Caelli, Ray, and Mill 2003).  
Qualitative research techniques are increasingly advocated for research on and in 
general practice (Chew-Graham, May, and Perry 2002; Jacoby, Smith, and Eccles 
2003; Jaye and Tilyard 2002; Watkins et al. 2003; Meyer 2000; Frederiksen, 
Kragstrup, and Dehlholm-Lambertsen 2009).  A further benefit of using a qualitative 
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descriptive study design is that it stays close to the data and to the surface of words 
and events, thereby producing a complete and valued end-point in itself, rather than 
serving as an entry point to further qualitative research (Sandelowski 2000; Caelli, 




The aim of sampling in quantitative methodology is to achieve representativeness 
whilst in qualitative methodology this involves saturation of information (Coyne 
1997; Teddlie and Yu 2007).  In mixed methods, researchers combine both 
quantitative and qualitative sampling in order to generate complementary databases 
that include information that have both depth and breadth regarding the phenomenon 
under study (Teddlie and Yu 2007).  
 
In a QUANqual design, the qualitative phase involves using a subsample of the 
quantitative sample (Teddlie and Yu 2007).  Therefore the sampling of respondents 
for the qualitative phase was drawn from DDs who had dispensed in the 2005-7 
fiscal years.  This may potentially restrict the number of respondents one can recruit 
for the ADD Study but it remains the aim of the qualitative phase to achieve both 
saturation10
 
 of information and equal representativeness of respondents. 
Interviews were conducted with a purposive sample of DDs.  Maximum variation 
sampling was utilised to include: 
• all states of Australia; 
• practices that are classified as ‘rural’ (RRMA 4 and 5) and ‘remote’ (RRMA 6 
and 7); 
• male and female; 
• current and past DDs who had dispensed in 2005-7 fiscal years; and 
• DDs who obtained their medical qualification in Australia or overseas (IMGs). 
 
Currently all Australian DDs specialised as GPs through the RACGP or ACRRM 
pathways.  The DD-respondents were recruited through Divisions of General 
                                               
10 Defined as when no new theme emerged from respondents who were interviewed late in the 
sequence. 
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Practice network and the RACGP.  Please refer to Appendices C and D for the letter 
of invite and information sheet. 
 
Doctors are notoriously hard to recruit for research (Cook, Dickinson, and Eccles 
2009).  The respondents who participated in this research were awarded 40 Category 
1 points under the RACGP Quality Assurance and Continuous Professional 
Development (CPD) Scheme for reviewing their own prescribing practices.  This 
activity was audited by the RACGP in 2009.  No financial or other incentives were 
offered to the respondents for participation in this study. 
 
2.3. Data Collection 
 
Data were collected through in-depth interviews with DD-respondents.  The 
interview was open-ended and informed by the quantitative findings. 
 
Written fax-back consent was received from the respondents before the interview 
was scheduled.  Before each interview was audiotaped, further verbal consent was 
sought from the respondents.  The respondents were assured they could withdraw 
from the study at any time without penalty and that confidentiality of information 
would be maintained. 
 
After each interview, the audiotaped conversation was transcribed verbatim on the 
Microsoft Word program within 24 hours, following which the language text was 
imported into NVivo software (version 8) for data management. 
 
A mixture of face-to-face interviews and telephone interviews was conducted to 
capture the data.  The use of telephone interviews was a practical solution as the 
respondents were geographically dispersed.  Recent evidence has indicated that 
telephone interview is a productive and valid methodological tool (Holt 2010): it 
enables a greater degree of control for the participants and is ideal for busy 
participants. 
 
Interviews with respondents were conducted between August 2009 and February 
2010, at a date and time of the respondent’s choice. In total, 25 formal interviews 
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were conducted with the 20 respondents.  Saturation of data was reached.  Ten face-
to-face interviews were held at the DDs’ medical practice and lasted 45 - 60 minutes. 
Fifteen interviews were conducted by phone and averaged 30 minutes; these included 
five subsequent formal follow-up interviews after the initial face-to-face contact.  
Once the preliminary analysis process was completed, a draft outline of the results 
was made available to the respondents for respondent validation. The respondents 
were offered an opportunity to make further comments; four respondents provided 
minor clarification and all feedback was incorporated into the final interpretation of 
the results.  Two other respondents who were not interviewed due to data saturation 
were also sent analyses of qualitative findings for validation. 
 
2.4. Data Analysis 
 
Data collection, coding and analysis were conducted concurrently throughout the 
stages of the study.  Content analysis guided the interpretation of data.  A 
combination of processes using qualitative content analysis (Sandelowski 2000; 
Miles and Huberman 1994) and constant comparison (Strauss and Corbin 1990; 
Glaser and Strauss 1967) were utilised to analyse the interview transcript 
thematically. 
 
Qualitative data analysis is data-driven and yet dynamic, as it allows researchers to 
continuously modify their treatment of data to accommodate new data and new 
insights about those data (Sandelowski 2000; Patton 1990; Pope, Ziebland, and Mays 
2000; Sivesind 1999; Bazeley 2007).  Differences and commonalities among sub-
groups of the respondents were noted.  Data saturation was considered to have been 
reached when the information began to be repetitive. 
 
Qualitative content analysis firstly involved familiarisation of the data through 
reading of transcripts.  Open coding of the transcript gave each discreet phrase a 
name that represented the phenomenon understudy.  This allowed the data to be 
examined closely with emphasis on detail.  The data were examined phrase by phrase 
to ascertain codes (free nodes) that described the meaning of what was occurring in 
the data.  The code words were often the very words or phrase used by the 
respondent.  Phrases and sentences within the data were given multiple codes if they 
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were identified as describing more than one meaning.  Many free nodes were 
subsumed into broader code words of higher conceptual level (tree nodes) as 
concurrent analysis of further data supported or modified the number of the codes. 
 
Secondly, the fractured data were put together in a ways that allowed connection to 
be made between categories and their sub-categories.  This involved displaying the 
preliminary analyses in a matrix, whereby every respondent is allocated a row and 
each column denotes a tree node.  This formed the basis for further inspection of data 
to identify links, patterns and contradictions within and between respondents, and 
development of main categories.  
 
Thirdly, respondent verification of factual and interpretive aspects of results was 
conducted for accuracy and credibility of findings.  Further data collection modified 
the advancing themes which involved asking questions more pertinent to the focus of 
the study.  The identification of further themes was grounded in the quantitative data.  
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• Unique factors that influence DD prescribing 
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DDs represented a very small group of GPs in the rural landscape.  Therefore, in 
pursuant to the privacy legislation (Privacy Act 1988 (Cth)  1988; WL v La Trobe 
University  2005; Holman 2010) and to protect the respondents’ identity, identifiable 
demographic data of the participants would not be provided.  Nevertheless, the 
respondents practised across all states of Australia.  Eight respondents (40%) 
practised in remote Australia and the remaining 12 respondents practised in rural 
Australia.  This concurred with the distribution of DD practices in Australia in which 
42% were classified as rural and 58% as remote.  There were six female respondents 
(30%), consistent with findings that one-third of country GPs are female (Health 
Workforce Queensland and New South Wales Rural Doctors Network 2009; Van 
Der Weyden 2005).  Eight of the respondents (40%) had completed their medical 
qualification outside Australia, consistent with similar reports that IMGs constituted 
40 - 50% of country GPs (Maxfield 2009; Gregory 2009).  Four respondents (20%) 
were no longer dispensing as at the time of the interview: two had recently retired 
and the others had lost their dispensing rights because a community pharmacy had 
opened up in the respective DD’s catchment area (Medicare Australia 2009). 
 
2. EXPLANATION FOR THE QUANTITATIVE FINDINGS 
 
2.1. Proportionally Fewer Scripts 
 
All respondents perceived that they had fewer patients “on the books” than their 
neighbouring non-dispensing counterparts with a pharmacy in town.  A majority of 
respondents (80%) did not think that their patient demographic spread was different 
to their non-dispensing peers as evidenced by NPS prescriber feedback and 
Medicare’s Program Incentive Payment statement which all GPs routinely received.  
Four respondents perceived that they might have fewer chronically ill patients on 
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their patient list, because the patients who required more intensive care tended to 
“ship out early” to bigger towns with more available health services. 
 
Two respondents indicated that they intentionally prescribed less so as to generate 
less paperwork, since “the more you prescribed the more you have to dispense”.  
According to all respondents, there were significant amounts of administrative 
“paperwork” associated with PBS dispensing; this was in addition to their usual 
medical practice.  Having to both prescribe and dispense meant that the respondents 
had to double-up on their time with each patient.  As one of the respondents 
indicated,  
If you are seeing patients both medically and as a pharmacist [sic] then you 
won’t much time to be a doctor, aren’t [sic] you?  So there are 40 hours in a 
week and if you are doing 10 hours dispensing then you are only able to do 30 
hours doctoring, aren’t you? 
 
The proportionally fewer scripts per DD observed in the earlier quantitative phase of 
the ADD Study may be explained by DDs having smaller patient populations, fewer 
medically ill patients and the desire to generate less administrative paperwork.  It is 
also plausible that DDs were spending less time with patients due to the 
administrative processes associated with dispensing PBS pharmaceutical benefits. 
 
2.2. Variability in Reg24 Use 
 
All respondents were aware of the legislative requirements for the use of Reg24.  The 
respondents, however, indicated that they only tended to use Reg24 for eligible 
patients with stable chronic conditions, pharmacotherapy that does not require 
regular monitoring, and those whom the respondents can “trust”; suggesting a further 
three caveats to use of Reg24, namely:  
(i)  chronic illness that had been stabilised,  
(ii)  pharmacotherapy that has a wide therapeutic index or that does not require 
stringent monitoring, and  
(iii)  patients whom the respondent perceived to be in concordance and compliance 
with their medical treatment/s. 
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One respondent expressed concern over the use of Reg24, since having all repeats 
and original pharmaceuticals dispensed to the individual patient at one time meant 
that the patient had to bear the cost of paying for all pharmaceuticals at one.  
Consequently this respondent imposed a further caveat to Reg24, i.e. ability to pay. 
 
Nine respondents (45%: 6 rural and 3 remote) expressed a preference for using 
Reg24 since that would mean less unnecessary travel for their patients.  Three 
respondents (15%: 2 rural and 1 remote) candidly admitted that for those eligible 
patients, use of Reg24 meant that they were able to increase pharmaceutical stock 
turnover despite losing out on dispensing fees associated with dispensing repeats. 
 
Three other rural respondents were frustrated that their Reg24 scripts which were 
provided to their patients and subsequently filled at a community pharmacy had been 
cancelled by the pharmacist.  As one respondent indicated, 
the pharmacist cancelled my Reg24, [this] happens a bit too frequently and you 
start to wonder why. … If a pharmacist is to cancel Reg24 they don’t call to tell 
me. 
 
The respondents were unable to provide further details as to why the pharmacist had 
cancelled his/her Reg24 scripts. 
 
The increased use of Reg24 by DDs as observed in the quantitative study may be 
explained by the patients having less accessibility to health services.  The wide 
variability in the use of Reg24 by some DDs may be explained by the additional 
criterion that DDs imposed on themselves before ordering Reg24.  There was a 
suggestion that some DDs might also use Reg24 to increase their stock turnover. 
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2.3. Similar Prescribing 
 
The respondents indicated that with the PBS dispensing licence, there was no 
requirement for them to attend additional CPD11
 
.  In addition, with the exception of a 
specific dispensing course previously coordinated by Health Workforce Queensland, 
there were also no training programs available which were specifically designed for 
DDs in regards to their dispensing role. 
All the respondents used different computer clinical software for prescribing and 
dispensing, and had policy and procedures in place with regard to dispensing.  
 
Other influences on prescribing set out below provided a further explanation for the 
general similarity in the prescribing outcome variables observed in the quantitative 
analysis. 
 
3. MAIN INFLUENCES ON PRESCRIBING 
 
With respect to what influences DDs’ prescribing, the respondents reported four 
main themes.  These were: 
1. peer pressure from non-DDs and pharmacists on prescribing,  
2. lack of support from the Guild for dispensing, 
3. availability of pharmaceutical stock, and 
4. perceived patient needs for doctor dispensin. 
 
3.1. Peer Pressure on Prescribing 
 
All respondents maintained there was a widely held view that DDs dispensed for 
profit and consequently their practices were associated with poorer quality use of 
medicines.  In support of this notion, the respondents reported various degrees of 
peer pressure and hostility from those against doctor dispensing.  These included 
                                               
11 Also referred to as Continuing Medical Education (CME).  It refers to all in-service training 
programs that supplement basic medical education and post-vocational training throughout a doctor’s 
professional working life.  In Australia, GPs are required to participate in a compulsory minimum 
number of CPDs for ongoing registration. 
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pharmacist groups, non-DDs and in some instance, their own patients.  Most 
respondents reported that pharmacists were generally against doctor dispensing as 
the dispensing of pharmaceuticals was considered to be the sole providence of the 
pharmacy profession.  The respondents indicated that pharmacists were concerned 
that if the doctor dispensed what he/she prescribed then there was no secondary 
check by a pharmacist; hence there was an elevated risk of medication error.  There 
also existed the potential for DDs to overprescribe and over-service.  For the non-
DDs, dispensing pharmaceuticals as part of routine medical practice was considered 
not the norm and not best practice, since DDs might be influenced by the additional 
source of revenue.  For the patients, the respondents indicated that some patients 
would still prefer pharmacist dispensing, not so much because of better 
pharmaceutical care, but rather because this would mean having an additional 
business in the town and an additional family for their isolated community.  
All the small country towns are very devoted to their community and any extra 
business is welcome. They would all prefer have a separate pharmacy, which 
would mean another family coming into town which would help their town 
community infrastructure and viability. 
 
DDs who represented a very small proportion of GPs and respondents generally 
stated they were inadequately represented by mainstream medical lobbyists and had 
no voice in the primary health care landscape. These barriers made DDs a vulnerable 
target.  This vulnerability promoted a number of responses. All respondents reported 
the need to be particularly vigilant about monitoring their own prescribing habits.  
For instance, through the confidential NPS prescribing feedback, which provided 
each individual prescriber with a breakdown of his/her own prescribing volume as 
compared to their peers in similar rurality.  DDs were often provided with assurance 
that they were “within the norm”.  On the infrequent occasions when the respondents 
were outside of the interquartile range, the prescribing feedback provided a basis for 
self-reflection and consequent correction. 
If I am a bad doctor the whole region knows about it. Dispensing doctors are 
already susceptible and other people are watching you. 
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All respondents felt they had to be proactive in acquiring knowledge about 
pharmacotherapy and most perceived themselves to be better informed about 
pharmaceuticals especially in terms of price and brand substitution.  
 
Additionally most respondents stated they needed to make an extra effort to foster 
professional relationships with existing health service providers in their catchments.  
Some respondents had even implemented a policy of not dispensing to patients who 
were residents of a neighbouring pharmacy town: 
We discourage people who live in the nearby town which has a pharmacist from 
having scripts filled here.  It is a public relations thing. 
 
For those respondents who were also the medical officer for their local hospital, all 
reported a positive collaborative working relationship with the hospital.  This 
included sharing pharmaceutical supplies between the DD’s dispensary and the 
hospital dispensary, since the hospital’s ability to source pharmaceutical supplies was 
often slower and involved more paperwork than that of the DD. 
 
Generally, respondents were not threatened by the prospect of a pharmacy opening 
up in their catchment despite the fact that this would mean an end to their PBS 
dispensing licence.  According to the respondents, since the Third Community 
Pharmacy Agreement was signed between the Commonwealth Government and the 
Guild in 2001, there had been at least eight DDs’ sites that had lost their PBS 
licences because of new community pharmacies.  The respondents generally saw 
pharmacists as valued health professionals.  
 
3.2. Lack of Support for Dispensing 
 
All except two of the respondents owned their own pharmaceutical stock.  This 
represented a significant financial investment.  The two respondents who did not own 
their stock offered affordability as an explanation.  Having a significant investment 
in pharmaceutical stocks was felt to contribute to remaining in that practice, and 
therefore professional retention.  Nevertheless, most respondents lamented that they 
could only hold a limited range of pharmaceuticals because of the high cost.  
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Consequently almost all of the DDs interviewed did not stock non-PBS subsidised 
pharmaceuticals.  This might also be partly due to respective state regulations on 
doctor dispensing.  
 
The respondents were annoyed that unlike the community pharmacists, DDs were 
not eligible for financial incentives to sustain their dispensary under any of the 
Community Pharmacy Agreements.  Under the Fourth Community Pharmacy 
Agreement (2005 – 2010), financial assistance to rural pharmacy practice included:  
• the rural pharmacy maintenance allowance (AUD$3,000 - AUD$38,000 per 
annum);  
• the pharmacy start-up allowance (AUD$100,000); or 
• a succession allowance when buying out an existing pharmacy (AUD$60,000) 
(Anderson 2005; Tatchell 2005; Minister for Health and Ageing 2005b; 
Pharmacy Review 2003; Minister for Health and Ageing 2007). 
 
Community pharmacies were also provided with: 
• AUD$14.5 million for broadband internet access (Minister for Health and Ageing 
2005a),  
• allowable extra fees of AUD$3.79 per item should the PBS dispensed price be 
below the general patient co-payment of AUD$32.90 (Commonwealth 
Department of Health and Ageing 2009a; Jensen 2009), and 
• a loading based on the pharmacy’s ARIA (Jensen 2009). 
 
According to the respondents, under the Fourth Community Pharmacy Agreement, 
the only financial incentive that DDs did receive was the capture of the patient’s 
Medicare card number; however, with the cessation of this incentive under the Fifth 
Community Pharmacy Agreement (commenced July 2010), DDs would not be 
entitled to any incentives under the Community Pharmacy Agreement.  All 
respondents felt frustrated that due to their lack of representation, they were unable 
to utilise any of the Commonwealth Government’s incentives to promote 
community-based pharmaceutical care.  For some of the respondents, dispensing was 
a “money losing business” because of significant investment tied up with stock and 
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yet they were not entitled to any of the incentives contained in the Community 
Pharmacy Agreement. 
I think it is unfair [emphasis added] that we don't get the same amount of 
support as pharmacist. They get decent funding when they set up a business and 
ongoing funds. In reality, dispensing is a money losing business as far as I am 
concerned unless you ignore medical ethics and prescribe medications for 
whatever the condition. 
 
The respondents also expressed concern over uncertainty in regard to some aspects 
of their dispensing rights, such as whether their practice nurse could assist with 
dispensing, similar to the arrangements in community pharmacy, where some aspects 
of dispensing were often delegated to the pharmacy assistant while still under the 
direct supervision of the pharmacist. 
 
3.3. Availability of Pharmaceutical Stock 
 
Respondents felt that they had been marginalised by the pharmaceutical suppliers 
because of their low buying power.  This was compared to the majority of 
community pharmacies that are part of a marketing chain with better bargaining 
power.  Pharmaceutical suppliers also imposed restrictions on DDs such as delivery 
of pharmaceutical supplies only on a fixed routine basis; usually once a week.  This 
is compared to the daily courier services that can be expected by a community 
pharmacy.  The major pharmaceutical suppliers also restricted the returns of unused 
pharmaceuticals from DDs.  This meant that DDs had to bear the cost and risk 
associated with holding their stock, for example when specially ordered 
pharmaceuticals lay unclaimed by patients or when the pharmaceutical reached its 
expiry date.  All respondents indicated that these factors influenced the type of 
pharmaceuticals they had in stock. For instance, as one respondent indicated,  
I am probably more anti-insulin. As you know insulin is an expensive drug to 
get, expensive drug to keep. Need refrigeration. To buy insulin need a couple of 
hundred dollars, so we are always very careful about ordering insulin making 
sure that people will definitely get it. You don’t want to get insulin and then 
people don’t get it. That can happen. 
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There was a lack of general agreement among the remaining respondents in regards 
to use of insulin.  No statistically significant differences in the prescribing of insulin 
between DDs and non-DDs was noted in the quantitative findings (3.45 vs. 3.58 
items per 1,000 scripts, p = 0.807).  The respondent’s comment above could be partly 
explained by further comments that rural doctors are generally more likely to 
prescribe therapy which required less monitoring. 
 
The respondents felt that they were penalised by having to compete with a 
neighbouring community pharmacy and/or mail-order pharmacy for price especially 
in regard to pharmaceuticals that cost less than the PBS co-payment.  Due to the 
combination of restrictions placed on pharmaceutical suppliers on supply and 
patients on demand, DDs generally had very low mark-up: “usually about 5%, no 
more than 10%”.  In most instances this resulted in the respondents having to sell 
pharmaceuticals at cost price, which “does not cover the cost of purchase and 
storage”.  To compound matters, according to the respondents, patients also had 
expectations that DDs would stock a wide range of pharmaceuticals, and they 
complained when DDs did not carry the particular branded pharmaceuticals they 
were prescribed by a specialist. 
 
With the limited stock range that DDs stock and have readily available, the 
respondents were generally not concerned that some 10 – 80% (median 40%) of their 
scripts ended up being dispensed by a neighbouring community pharmacy or via 
mail-order pharmacy.  Most acknowledged that patients would take their routine 
non-urgent PBS scripts with them to be filled by the community pharmacy in a major 
regional centre when they next travelled there for routine shopping.  Consequently 
DDs’ patients tended to utilise the DDs’ dispensary for more urgent medications 
such as adrenergic inhalants and antibiotics. 
 
Since the DDs own and manage the stock, they were more aware of pharmaceutical 
costs and availability.  Respondents reported stocking mainly generic 
pharmaceuticals.  With the different proprietary names, the respondents indicated 
that they were conscious of the potential for confusion and consequently spent more 
time explaining the purpose/s of use and brand substitution to their patients.  
Nevertheless, the respondents indicated that the ultimate preference remained with 
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the patient and DDs would either specifically order the particular branded 
pharmaceutical in for the patient, or provide the patients with a script to be filled 
elsewhere.  Some respondents reported contacting the neighbouring community 
pharmacy to ensure that the particular branded pharmaceutical was available before 
dismissing the patient with the relevant script. 
 
3.4. Patients’ Needs for Doctor Dispensing 
 
When asked why they took on the additional dispensing role respondents universally 
acknowledged that the main reason was for the convenience and benefit of their 
patients and to ensure continuity of care.  DDs’ communities were generally more 
isolated and smaller when compared to their non-dispensing counterparts.  In terms 
of distance, the respondents indicated that the nearest neighbouring community 
pharmacy ranged from 50 to 200km (median 70km) away from their practice.  
Therefore the respondents viewed their dispensary as a service to the community. 
 
Respondents indicated that because of their prescribing and dispensing roles they had 
more contact with patients, more comprehensive knowledge of their conditions, and 
consequently were better placed to aid compliance.  Additionally, when dispensing 
repeat prescriptions they were also able to take advantage of the opportunity to 
informally consult and counsel their patients.  For instance,  
When someone comes in and said, they bought two Ventolin [salbutamol: short-
acting β2-adrenegic inhalant] puffers in the last two weeks, then you say you 
have to come in.  Very often it is opportunistic; you can check the asthma out.  
Gives you a good opportunity to opportunistically see people.  If someone is 
coming in to get too many cold-and-flu’s then you know they are stocking up on 
their codeine tablets whilst if you are non-dispensing doctors, you won’t see 
that.  Unless the chemist specifically sent a message to the doctor concerning 
the patients’ consumption then you don’t know.  They have to be quite bad 
before a chemist does that; so you can pick up the inappropriate counter stuff 
earlier. 
 
All respondents felt that they had a better appreciation of patients’ social needs and 
were in a better position to respond, particularly to the patient’s economic needs. 
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If the patient said I can’t afford or I would come back another day to pick it up 
or something like that, I would actually enquire if they have problem with money 
or what the problem was or something like that. We try to help out to make sure 
that they have their medication. Look, if there was time when I thought it was 
really important I ended up paying for it. So right from dispensing them that 
knowing I wasn’t going to get paid right through to organising a generic or 
ringing up to get a special authority or something like that to help people. 
Particularly in the case of the children, there have been times when I knew that 
the parents either couldn’t or wouldn’t be able to afford to buy antibiotics or 
such stuff for their kids. At the end of day I make sure they get it. 
 
4. SUMMARY OF FINDINGS 
 
Prescribing is a complex decision making task.  There are many factors that can 
influence prescribing (Jacoby, Smith, and Eccles 2003; Tobin et al. 2008; Jaye and 
Tilyard 2002; Cutts and Tett 2003a, 2003b; Cockburn and Pitt 1997; Henriksen and 
Hansen 2004; Hemminki 1975; Maronde et al. 1971; Lim and Rowett 2006; 
Mansfield 2008; Stocks et al. 2009; Puspitasari, Aslani, and Krass 2009; Frich et al. 
2010; Breen 2004; Lundin 2000; Kringos et al. 2010).  In this study four major 
factors which were unique to DDs and not previously described elsewhere, were 
identified.   
 
Respondents believed that there were expectations from their peers (non-DDs and 
pharmacists) that DDs over-serviced their patients and prescribed less judiciously.  
To protect themselves, respondents were more vigilant about their own prescribing 
and actively sought knowledge about pharmacotherapy. 
 
As an individual group, DDs were professionally isolated, and felt unrepresented and 
almost invisible to their professional bodies and to policy makers.  Consequently, 
respondents actively foster working relationships with existing health professionals, 
including pharmacists and local hospitals.  Respondents viewed pharmacists as 
valuable professional colleagues. 
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Respondents were committed to their patients despite the significant barriers that 
they confronted with their dispensing function.  DDs did not receive support, 
professionally or financially for their dispensing role.  However, it was noted that 
respondents who invested heavily in their pharmaceutical stock were more prepared 
to stay in their community. 
 
The ability of DDs to prescribe and dispense meant that the respondents were able to 
offer a one-stop shop for their patients in terms of their medical and pharmaceutical 
care.  Respondents indicated that they had more comprehensive knowledge of their 








If I am a bad doctor the whole region knows about it. Dispensing 
doctors are already susceptible and other people are watching you ... 
 
We discourage people who live in the nearby town which has a 
pharmacist from having scripts filled here, it is a public relation 
thing. 
 
All the small country towns are very devoted to their community and 
any extra business is welcome. They would all prefer have a separate 
pharmacy, which would mean another family coming into town 






I think it is unfair that we don't get the same amount of support as 
pharmacist. They get decent of funding when they set up business and 
ongoing funds. In reality dispensing is money losing business as far 
as I am concerned unless you ignore medical ethics and prescribe 
medications for whatever the condition. 
 
HIC funding for community pharmacies specifically excludes 
dispensing GPs. This includes the start-up grant, which is basically 
aimed at allowing you to buy base stock. I know that for me there 
was no way that I could afford that baseline stock, which is why I run 






As a DD I am probably more anti-insulin. Insulin is an expensive 
drug to get, expensive drug to keep. Needs refrigeration. To buy 
insulin you need a couple of hundred dollars, so we are always very 
careful about ordering insulin making sure that people will definitely 
get it. You don’t want to get insulin and then people don’t get it. That 
can happen. 
 
Dispensing GPs are compelled to sell expensive medicines at cost 
price or others at $4.85, both of which do not cover the costs of 






If the patient said I can’t afford … we try to help out to make sure 
that they could have their medication. Times when I thought it was 
really important, I ended up paying for it: from dispensing them and  
knowing I wasn’t going to get paid, right through to organising a 
generic or ringing up to get a special authority or something like that 
to help people. Particularly in the case of the children, there have 
been times when I knew that the parents either couldn’t or wouldn’t 
be able to afford to buy antibiotics for their kids. At the end of day I 
make sure they get it. 
 






Health inequity exists between urban and rural Australians (see Chapter III).  A 
multidisciplinary model of organising and providing care has been proposed as a 
means to decrease the health gap (Duckett 2005a; Van Der Weyden 2005; 
Wakerman et al. 2005; Duckett 2006; Gupte 2007; National Rural Health Alliance 
2008a; Wakerman et al. 2008; Dunbar and Reddy 2009; Wakerman 2009; Wong and 
Regan 2009; Smith 2010) but this is not feasible for all rural communities because of 
rural health workforce shortages and higher costs of providing health services in 
rural Australia (Wakerman and Humphreys 2002; Wilson, Oldenburg, and Lopez 
2003; Sims and Bolton 2004; Dunbar et al. 2007; Towler 2007; Gorman and Brooks 
2009; Scott 2009; Wilson et al. 2009; Haines et al. 2010; O'Toole, Schoo, and 
Hernan 2010). 
 
Amongst the options, flexibility and expansion of the range of tasks that a health 
professional can undertake have been proposed.  DDs in Australia are a long 
standing example of an application of such flexibility through an expansion of 
normal GP roles.  The granting of a PBS dispensing licence to a rural GP is intended 
to improve rural community access to pharmaceutical care where there is no 
pharmacy within a reasonable geographical distance.  
 
Doctor dispensing of pharmaceuticals is not new.  In Australia for example almost all 
doctors have dispensed pharmaceuticals for their own patients at one time or another.  
Often this has taken the form of drug samples or starter packs which are offered to 
patients without charge.  Reasons for doctors dispensing starter packs include trials 
of new pharmacotherapy, familiarising themselves with the efficacy and tolerability 
of a new pharmaceutical, increased access to pharmaceutical care for patients who 
cannot or are unable otherwise to afford it, and access to pharmaceuticals that are not 
yet on the PBS.  The practice of doctor dispensing starter packs is the subject of 
much controversy.  These include their use as a marketing tools for the 
pharmaceutical industry and the potential for medication errors (Ashley, Kirk, and 
Fowler 2002; Hall, Tett, and Nissen 2006; Patounas and McGuire 2007; Spurling and 
Kyle 2007; Kyle, Nissen, and Tett 2008). 
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An even more contentious issue is that of doctors dispensing pharmaceuticals for 
profit.  In Australia, between 2005 and 2007, there were 72 DDs who routinely 
dispensed PBS subsidised pharmaceutical benefits to their patients and in return were 
remunerated with a dispensing fee. 
 
In a systematic review on DD practices internationally, it was reported that overseas 
DDs tended to prescribe more pharmaceutical items, incurred higher pharmaceutical 
costs and were less likely to prescribe generically than their non-dispensing 
counterparts.  There was also evidence that DDs prescribed antibiotics less 
judiciously and were associated with poorer dispensing standards. 
 
In the quantitative phase of the ADD Study, PBS administrative data for the 2005-7 
fiscal years were analysed against pre-determined volume and prescribing indicators.  
Pre-determined indicators were chosen so as to enable comparison with overseas DD 
findings.  In this study, there were no substantive differences between the PBS 
prescribing practice of DDs and non-DDs with the exception of fewer patients per 
doctor, fewer PBS scripts per doctor, more Reg24 use among DDs, more adrenergic 
inhalants, and more NSAIDs and penicillin-type antibiotics.  The validity of the 
number of PBS prescriptions per doctor was affected by the increased rate of Reg24 
use among DDs.  Arbitrary adjustment of the volume indicator suggested that DDs’ 
prescribing might be similar to those of non-DDs.  This study was limited by what 
can be done to correct the data: for instance modelling could not be performed to 
explain the variability in Reg24 use.  Notwithstanding this, the study finding was at 
variance with overseas findings. 
 
The DD-respondents in the qualitative phase of the ADD Study validated that they 
had smaller patient populations than their non-dispensing peers.  The increased 
Reg24 use was due to the accessibility issue since DD practices were more remote 
and isolated.  A wide confidence interval among DD cohorts for Reg24 use was 
noted in the quantitative analysis.  This might be due to the issue of matching based 
on rurality.  The study had initially asked for matching based on the ARIA whereas 
the actual data released by the Department was extracted based on the RRMA index 
of the individual prescriber.  The ARIA was preferred over the RRMA for this study 
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since the former included road distance to goods and services as well as population 
size in its criteria.  An early descriptive study conducted in WA observed that DD 
practices were more remote and had fewer available services in their towns as 
compared to similar medical practices in the same RRMA (Lim, Gray, and Roach 
2004).  This was affirmed in this study.  Therefore it is possible that the variability in 
access to other goods and services was not appropriately corrected for based on 
RRMA.  This in turn might explain why a statistically significant difference was 
noted in the rural cohort and not in the remote cohort.  Regardless of this, it is not 
possible to correct completely for all the differences in rurality since rural 
communities are not homogeneous. 
 
There was some suggestion from respondents that some DDs might prefer to use 
Reg24 to increase stock turnover.  However, the respondents defended their use of 
Reg24 by imposing upon themselves stringent criteria above and beyond those 
required by the legislation such as the patients’ ability to pay, patients whom DDs 
can trust, and medical condition/s which was/were stable and treatment regimens 
which did not require stringent follow-up.  The increased use of Reg24 posed 
important quality use of medicines considerations: medication wastage from expired 
drugs, inappropriate storage, and change in patients’ medical condition.  There is also 
the issue of heightened risk of medication misadventure due to having more 
pharmaceuticals physically available.  Home Medicines Review12
 
 has been shown to 
reduce medication misadventure (Rowett 2005) and would be beneficial to DDs’ 
patients.  DDs have reportedly used this in the past. 
Key findings from the qualitative study were that with smaller patient population per 
doctor, the ability of DDs to dispense had made it attractive for local residents to 
continue to visit and support their local GPs (DDs) knowing that they (the residents) 
can have immediate access to medical and pharmaceuticals benefits if required.  
Without the DD dispensary, the residents would have to travel a great distance to a 
neighbouring pharmacy town for their pharmaceutical care.  In addition, respondents 
                                               
12 Also known as ‘Domiciliary Medication Management Review’ was funded since the Third 
Community Pharmacy Agreement whereby a pharmacist would visit the patient’s home to document 
medication related issues and a report generated by a consultant pharmacist will be then forwarded to 
the GP.  The intention is such that both pharmacist and GP work collaboratively in managing patient’s 
pharmaceutical care. 
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who invested heavily in their pharmaceutical stock were more prepared to stay in 
their community.  It is possible that the model of doctor dispensing actually 
contributed to sustainability of what would be otherwise unviable rural general 
practice through a combined revenue source from two unviable stand-alone practices.  
This proposition might be attractive if there was a small patient population and the 
“free time” that the rural GP has from consulting is spent instead on dispensing, but it 
remains unclear at what threshold the patient population does not justify such a 
practice and the GP’s time is better spent consulting rather than in the combination of 
the two activities. 
 
A key reason offered by the respondents for why they choose to dispense was the 
ability to better respond to patients’ needs.  From the literature, there was strong 
evidence that comprehensiveness of care is a strength of primary care.  Primary care 
and social determinants of health share much in common and health services which 
do not consciously address social determinants exacerbate poor health outcomes.  
Respondents indicated that through both prescribing and dispensing, DDs were more 
familiar with their patient’s medical and social needs.  Consequently DDs were in a 
better position to respond to patients needs.  Therefore the model of doctor 
dispensing provided a consistent and coherent approach to management continuity in 
rural Australia. 
 
Dispensing of PBS pharmaceutical benefits for DDs is not without its difficulties.  
For instance, the Commonwealth Government granting of a PBS dispensing licence 
to a doctor-applicant is subject to strict administrative criteria, which include no 
objection from neighbouring community pharmacies, and the doctor-applicant 
establishing needs and public interest benefits.  Furthermore, the DD’s PBS 
dispensing licence is automatically cancelled without warning should a pharmacy 
open up in that area.  Despite this, there appears to be no animosity evident towards 
the pharmacy profession.  Instead the respondents actively fostered professional 
relationships with existing rural health professionals through the policy of not 
dispensing to patients from pharmacy-towns and sharing of pharmaceutical stock 
with their local hospital.  Issues with inter-professional conflict pertain to the lack of 
financial support from the Pharmacy Guild for DD’s dispensing roles.  Regardless of 
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this, it may not be feasible for the Guild to support DDs as doing so would mean 
endorsing an alternative model of pharmacy practice in Australia. 
 
Other barriers that were experienced by DDs were similarly experienced by rural 
community pharmacies, for instance the cost of owning one’s stock and the risk 
associated with it.  DDs may arguably have lower risk than rural community 
pharmacies since DDs are able to prescribe what they have in stock.  A plausible 
explanation for why the majority of the respondents ranked stock holding as a major 
barrier is suggested that some respondents were not used to managing a commercial 
business with significant stock holding.  Previously under the Fourth Community 
Pharmacy Agreement, community pharmacies were offered a financial incentive to 
assist Aboriginal Medical Services with managing their stock holding under the 
Section 100 Scheme (Emerson, Bell, and Croucher 2001; Emerson, Croucher, and 
Burchell 2001; Loller 2003; Hope 2010).  A future Pharmacy Agreement should 
consider a similar scheme to assist DDs in managing their stock without diminishing 
the DDs’ important contribution to their community. 
 
Respondents indicated that due to the cost of pharmaceutical stock they tended to 
prescribe and dispense generically.  Consequently the respondents spent more time 
explaining and discussing generic substitution with their patients.  Health literacy 
among mainstream health consumers on generic substitution is low and verbal 
instruction can significantly increase health literacy (Emery et al. 2010; Emmerton, 
Kairuzm, and McKauge 2010; McKenzie 2010a) and reduce potential for adverse 
drug events (Travaglia 2010).  Therefore DDs’ increased use of generics may 
contribute to a more sustainable PBS (Clarke and Fitzgerald 2010) and improve rural 
health literacy regarding generic substitution. 
 
In terms of potential medication misadventure, there was no strong evidence in the 
quantitative analysis that DDs prescribed significantly differently to non-DDs 
measured against the study’s pre-determined prescribing indicators.  The increased 
proportion of NSAIDs, adrenergic inhalants and penicillins used was explained by 
the respondents by their inability to dispense non-PBS subsidised pharmaceuticals.  
In addition, all respondents prescribed electronically.  Electronic prescribing had 
been previously shown to reduce medication errors (Powell-Davies and Fry 2004; 
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Deans 2005; Bomba and Land 2006; McInness, Saltman, and Kidd 2006; 
Ammenwerth et al. 2008; Moxey et al. 2008; Pirotta 2010).  Furthermore, 
respondents concomitantly used separate dispensing and prescribing software, so that 
this is also likely to further minimise medication errors since prescribing software 
has high sensitivity but low specificity compared with dispensing software, which 
has low sensitivity but high specificity (Sweidan et al. 2008; Sweidan et al. 2009).  
DDs having both electronic infrastructures might be well placed to adapt to the new 
Commonwealth Government e-health initiative (Haikerwal 2009a). 
 
As compared to overseas DD health models, there appear to be sufficient safeguards 
in place to assist Australian DDs.  These include the routine NPS prescriber feedback 
(administrative), and the self-perceived need to be better prescribers in order to 
protect themselves from peers’ scrutiny (psychology).  Overall, the section 92 13
• Appropriate: there is no strong evidence to suggest that DDs prescribed 
differently. 
 
doctor dispensing model is: 
• Efficient/ cost-effective in use of resources: the small DDs’ community size 
would not be able to support a viable community pharmacy and through doctor 
dispensing, patients have ready access to pharmaceuticals should they desire 
them (ensuring continuity of pharmaceutical care).  The revenue from dispensing 
combined with that from the general practice sustains what would be an 
otherwise unviable rural practice. 
• Responsive/ choice of provider: respondents indicated that the patients have the 
choice from whom and where they want the script to be filled.  This is also 
supported by the previous pilot study on WA DDs (Sunderland, Burrows, and 
Joyce 2005; Sunderland, Burrows, and Joyce 2006). 
• Accessible: respondents indicated that they were better aware of the patient’s 
medical and social needs, and had dispensed at no cost on occasion to ensure 
access to pharmaceuticals. 
• Safe care: the quantitative study suggested that DDs’ PBS prescribing was similar 
to that of rurality-matched non-DDs.  
                                               
13 National Health Act 1953 (Cth). 
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• Continuous/ coordinated care: respondents indicated they actively fostered 
working relationships with other health providers.  The respondents also indicated 
that in instances when their dispensary did not stock a particular pharmaceutical, 
they would call ahead to the neighbouring community pharmacy to ensure that 
stock was available or alternatively order in the pharmaceutical specifically for 
the patient concerned. 
• Capable: respondents indicated that they were more knowledgeable about 
pharmaceuticals than their non-dispensing peers and had proactively sought out 
information on pharmacotherapy.  This echoed overseas studies that DDs were 
more knowledgeable (Pink, Hageboeck, and Moore 1989; Faisst, Schilling, and 
Gutzwiller 2000; Ogbogu et al. 2001). 
• Sustainable: having invested heavily in the pharmaceutical stock, respondents 
were prepared to stay in their community.  Surveyed patients in the pilot study 
generally supported DDs’ general practice (94.1% DDs’ vs. 95.6% non-DDs’) 
(Sunderland, Burrows, and Joyce 2005). 
 
Unfortunately, according to the respondents, there is no evidence of endorsement for 
this valuable service in rural and remote Australia.  As a unique group, Australian 
DDs are largely invisible in the mainstream health system, representing only 0.36% 




No substantive evidence was found that rural and remote DDs prescribed at 
significantly higher rates than their non-DD colleagues.  The major difference was on 
Reg24 use by rural DDs.  As a model for delivering primary care in remote areas it 
appears to operate satisfactorily for the DDs and their communities.   
 
The current PBS remuneration system depends on throughput to generate revenue.  
This fee-for-service model may encourage DDs to prescribe more and hence 
dispense more.  However, there is no strong evidence from the ADD Study to 
support this assumption or that DDs prescribe significantly differently from non-DDs.  
DDs are not a threat to the pharmacy profession and DDs choose to dispense not 
solely for personal gain, and are doing so in the absence of financial support.  DDs 
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commented that, by their investing heavily in their pharmaceutical stock, they are 
ready, willing, and able to stay in rural Australia.  This is of particular importance in 
light of difficulties in recruiting and retaining rural health professionals.  The model 
of doctor dispensing may potentially provide one interim solution to recruitment and 
retention of rural doctors.  For instance, one of the respondents had practised in the 
same dispensing practice his entire medical career (>46 years)!  With the recent 
reductions in income from the PBS to community pharmacies, and rumours of 
further reductions in PBS remuneration (Australian Journal of Pharmacy 2010; Eton 
2010; Sclavos 2010), this has meant that the role of DDs may become more 
important in rural Australia should community pharmacies close down, as they did in 
the1980s.  Therefore, if governments are genuinely interested in the value of primary 
care and rural health, the model of doctor dispensing should not be ignored. 
 
2. RECOMMENDATIONS FOR PRACTICE 
 
2.1. Acknowledgement of DD Services 
 
Primary care was offered by the current Federal Labor (Rudd) Government as the 
solution to address many of its health reform priorities (National Preventive Health 
Taskforce 2009; Commonwealth Department of Health and Ageing 2009d, 2009c; 
Royal Australian College of General Practitioners 2010; Australia Medical 
Association 2009; National Health and Hospitals Reform Commission 2009).  The 
Australian DD health model, until now, has been an isolated and poorly documented 
general practice model in Australia.  To sustain the current DD services in rural and 
remote communities, governments, pharmacy and medical regulatory authorities 
firstly need to recognise and acknowledge the existence and contribution that DDs 
make to their community. 
 
2.2. Support Structures to be Formulated to Assist DDs 
 
Significant barriers currently exist to doctor dispensing.  The actual number of DDs 
practising in Australia is small, and therefore the cost of supporting DDs is not 
expensive, considering that infrastructure already exists to support rural community 
pharmacies.  DDs should be able to tap into these support infrastructures such as the 
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Section 100 Scheme to assist them with managing their pharmaceutical stock, and be 
able to directly refer patients for the Home Medicines Review Service.  This may be 
ideally be facilitated through a medical organisation such as Rural Doctors 
Association of Australia, instead of the Guild, for political reasons. 
 
2.3. Support for Practice Nurse or Dispensary Assistant 
 
The extent to which a DD can delegate his/her dispensing to a practice nurse or 
dispensary assistant needs to be clarified by the Commonwealth and respective State 
Governments.  Curricula and supports for training practice nurses or dispensary 
assistants in dispensing are already in place for training community pharmacy 
assistants.  The support for such training schemes, which is currently available from 
the Pharmacy Guild through Community Pharmacy Agreements, should also ideally 
be extended to DDs’ practice nurses or dispensary assistants to ensure that DDs’ staff 
have minimum accredited training.  This does not diminish the responsibilities and 
obligations that a DD has over his/her dispensary such as the need to supervise the 
dispensing and be available for providing further information and consultation with a 
patient. 
 
2.4. Standardisation of Dispensing Requirements 
 
Currently DDs are subjected to both Commonwealth legislation for their PBS 
dispensing licence and respective State Government legislation for holding a poisons 
licence.  This has resulted in most DDs being unable to dispense non-PBS subsidised 
pharmaceutical benefits.  Being able to dispense non-PBS subsidised 
pharmaceuticals would improve DDs’ patients’ access to a wider range of 
pharmaceuticals products.  Currently DDs’ patients are accessing non-PBS 
pharmaceuticals through mail-order or when they travel next to a pharmacy town 
(Sunderland, Burrows, and Joyce 2005).  The ability of the DD to stock non-PBS 




3. RECOMMENDATIONS FOR RESEARCH 
 
3.1. DDs’ Dispensing Standards 
 
The focus of this study was on the evaluation of DDs’ PBS prescribing and did not 
focus specifically on DDs’ dispensing.  Observational data from Zimbabwe 
suggested that their DDs’ dispensing was contrary to best dispensing practice 
(Hansen and Trap 2004; Trap 2001).  Therefore evaluation of Australian DDs’ 
dispensing would provide a more comprehensive picture as to the appropriateness of 
DDs’ service in country Australia.  It may be difficult to obtain agreement for this to 
occur. 
 
3.2. Reduction in Health Gap 
 
Respondents from the current study stated that they were better able to respond to a 
patient’s medical and social needs.  Other gaps remained such as access to medical 
specialists and allied health professionals.  Due to issues with privacy and 
confidentiality, this study was unable to perform any modelling of the quantitative 
findings or be able to link prescribing accurately.  Therefore a future study focusing 
on patient’s outcomes would be able to ascertain objectively the clinical 
effectiveness of the Australian DD health model and whether this is a plausible 
means to reduce health inequity between rural and urban communities.  
 
As suggested earlier, an economic modelling study may be warranted to ascertain 
whether there is an optimal patient number to justify DDs in their dual roles and at 
what point, after that number, DDs would be overwhelmed, overworked and 
negatively impact on their standard of care. 
 
3.3. Influences of DDs’ Prescribing 
 
As indicated above in the systematic review, there has been no study that expressly 
addresses what influences DDs’ decision-making process when prescribing.  Much 
remains unknown about whether the four unique influences identified in this study 
are consistent with overseas DD models. 
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3.4. Other Methods of Pharmaceutical Delivery 
 
A future study should examine whether the DD model is most appropriate for small 
communities as compared to other options such as mail-order, use of pharmacy 
depots, medicine-dispensing ATMs, telemedicine and telepharmacy.  Another 
alternative is the script collection services practised in some rural Australia towns 
and in parts of the UK where a nearby pharmacy collect the script (physically or 
electronically) from the general practice, have the pharmaceuticals ready to be 
picked up or home delivery the next day or use of a non-pharmacy depot (Australian 
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Dispensing Doctors (ADD) Study. Medical Journal of Australia (Pending 
revision). 
• Lim, D., Emery, J., Lewis, J., and Sunderland, V.B. Influences of dispensing 
doctors' practice: qualitative findings from the Australian Dispensing Doctors 
(ADD) Study. Medical Journal of Australia (Pending revision). 
 
2. PEER REVIEWED CONFERENCE 
• Lim, D., J. Emery, J. Lewis, and B. Sunderland. 2010. Old Players, New 
Findings from a sequential explanatory mixed methods study on the 
prescribing practices of dispensing doctors: Australian Dispensing Doctor 
(ADD) Study. In National Medicines Symposium 2010: the Medicines 
Environment is changing Daily. Are you keeping up? National Prescribing 
Service and National Medicines Policy Committee, Melbourne, Victoria. 
o This symposium was attended by 560 delegates from 15 countries. 
• Lim, D., J. Lewis, and V. B. S. J. Emery. 2009. Why doctors dispense? In 2009 
State PHCRED Conference: The Future of Primary Health Care - Working 
Together. Royal Australian College of General Practitioners & Primary 
Healthcare Research, Evaluation and Development (PHCRED) WA, Floreat, 
Western Australia. 
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o This conference was attended by 60 primary healthcare practitioner delegates 
from Perth.  This paper presentation was based on preliminary findings from 
Chapter VII Qualitative on why DD dispensed. 
• Lim, D., J. Emery, J. Lewis, and B. Sunderland. 2009. Dispensing in the bush: 
a comparison of prescribing patterns between dispensing and non-dispensing 
doctors. In Australia in GP'09: the Conference for General Practice 2009. 
Royal Australian College of General Practitioners, Perth, Western Australia. 
o This conference was attended by 750 general practitioner delegates across 
Australia.  This poster presentation was based on differences observed in 
DDs’and non-DDs’ PBS prescribing (volume indicators and antibiotics 
prescribing indicators) as was presented in Chapter V Quantitative. 
• Lim, D., and Lewis, J. 2009. Could mixed method be the solution to political 
sensitive research: experience from the Australian Dispensing Doctors Study. 
In 5th Annual Mixed Methods Conference. University of Leeds, Harrogate, 
England. 
o This conference was attended by 200 academic delegates from 32 countries.  
This oral presentation presented the methodology for the ADD Study and built a 
case for mixed methods design study in legislative evaluation. 
• Lim, D., Sunderland, V.B., and Emery, J. 2008. Practices of dispensing doctors. 
In 2008 State Conference: Primary Health Care MATTERS!. Royal Australian 
College of General Practitioners & Primary Healthcare Research, Evaluation 
and Development (PHCRED) WA, Fremantle, Western Australia. 
o This conference was attended by 80 primary healthcare practitioner delegates 
from Perth.  This paper presentation presented partial findings from the 
systematic review contained in Chapter II Literature Review.  This presentation 




APPENDIX B – Systematic Review Data Extraction Sheet 
 
SOURCE SIGN Rating: 
Funding source  
Country  
Sample  
Source of data/ Study type  
Design method  
Objective(s)  





Reviewer’s comments  
 
























SIGN levels of evidence 
1++ High quality meta-analyses, systematic reviews of RCTs, or RCTs with a very low risk of bias 
1+ Well conducted meta-analyses, systematic reviews of RCTs, or RCTs with a low risk of bias 
1- Meta-analyses, systematic reviews or RCTs, or RCTs with a high risk of bias 
2++ 
High quality systematic reviews of case-control or cohort studies, or high quality case-control or cohort 
studies with a very low risk of confounding, bias, or chance and a high probability that the relationship is 
causal 
2+ Well conducted case-control or cohort studies with a low risk of confounding, bias, or chance and a moderate probability that the relationship is causal 
2- Case-control or cohort studies with a high risk of confounding, bias, or chance and a significant risk that the relationship is not causal 
3 Non-analytic studies e.g. case report 
4 Expert opinion 
Table B.2:  Scottish Intercollegiate Guidelines Network levels of evidence 




SIGN grades of recommendations 
A 
At least one meta-analysis, systematic review or RCT rated as 1++ and directly applicable to the 
target population or a systematic review of RCTS or a body of evidence consisting principally of 
studies rated as 1+ directly applicable to the target population and demonstrating overall 
consistency of results 
B 
A body of evidence including studies rated as 2++ directly applicable to the target population 
and demonstrating overall consistency of results or extrapolated evidence from studies rates as 
1++ or 1+ 
C A body of evidence including studies rated as 2+ directly applicable to the target population and demonstrating overall consistency of results or extrapolated evidence from studies rated as 2++ 
D Evidence level 3 or 4 or extrapolated evidence from studies rated as 2+ 
Table B.3:  Scottish Intercollegiate Guidelines Network grades of 
recommendations (Harbour and Miller 2001). 
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APPENDIX C – Letter to Dispensing Doctors 
 
 
School of Public 
Health 
GPO Box U1987 
Perth    WA    6845. 
 
Telephone +61 8 9266 7819 







My name is David Lim and as part of my Doctor of Public Health thesis entitled 
“Prescribing Practices of Australian Dispensing Doctors” I am seeking opinions from 
GPs who dispensed PBS pharmaceuticals to their patients. The objective of this study is 
to provide a more accurate picture of dispensing doctors’ prescribing practices in 
Australia through the analysis of national PBS claims data. 
 
We have recently analysed the pooled, de-identified 2005-7 PBS scripts for dispensing 
and non-dispensing GPs. We would very much like to have your input so as to have a 
better contextual understanding of the result. 
 
I hope you will consider participating as your opinions are important to us. This project 
has been approved by Curtin University Human Ethics Committee (HR38/2007 and 
SPH48/2008) and qualifies for 40 (Category 1) RACGP QA&CPD points (2007-9 
triennium, activity number 742557). 
 






APPENDIX D – Letter to Divisions of General Practice 
 
 
School of Public 
Health 
GPO Box U1987 
Perth    WA    6845. 
 
Telephone +61 8 9266 7819 





Dear [Division of General Practice], 
 
My name is David Lim and I am a doctoral student in the School of Public Health at Curtin 
University in Western Australia. As part of my Doctor of Public Health thesis entitled 
“Prescribing Practices of Australian Dispensing Doctors” I am seeking opinions from rural 
and remote doctors who dispensed PBS pharmaceuticals to their patients. 
 
Some international studies have demonstrated differences in prescribing between 
dispensing and non-dispensing doctors. I have recently compared some characteristics of 
PBS scripts between Australian dispensing and non-dispensing doctors, nationally; and 
would like to speak with dispensing doctors to seek their opinions about the differences 
observed as well as to gain a better insight into issues that may influence prescribing. 
 
I have attached to this letter a letter of invitation to participate. It would be very much 
appreciated if you can forward this to your dispensing doctor/s. 
 
This project has been endorsed by some dispensing doctors and Divisions of General 
Practice. This project has been cleared by Curtin University Human Ethics Committee and 
RACGP QA&CPD points have been allocated for participation. 
 
Should you require more information please do not hesitate to contact me on mobile 0429 





APPENDIX E – Consent Form 
 
 
School of Public 
Health 
GPO Box U1987 
Perth    WA    6845. 
 
Telephone +61 8 9266 7819 





The purpose of the interview is to seek your opinions as to the practices of dispensing 
doctors in Australia and to help explain the differences in the characteristic of PBS 
pharmaceuticals prescribed and dispensed by dispensing doctors. 
 
The phone interview should take approximately 30 minutes and will be audio-taped. 
After the interview, the conversation will be transcribed and any identifiable 
information about you or your practice will be removed. Following transcription, the 
audio-recording will be destroyed. De-identified transcribed files will be maintained on 
a password protected computer at Curtin University. Access to the computer will be 
restricted to David Lim and his supervisors. The data collected will be analysed in 
aggregate terms only. 
 
Participation in this research is strictly voluntary. All information that is collected is 
confidential and at no time will your individual comments or identity be released to a 
third party. Please understand that you are free to withdraw at any time during this 
research if you so wish and to remove any opinions that you may have contributed. 
 
Any questions concerning this research can be directed to David Lim on 0429 922 033 
or email chee.lim@postgrad.curtin.edu.au or supervisor Jan Lewis on (08) 9266 2075. 
 
I (the informant) have read the information above and any questions I have asked have 
been answered to my satisfaction. I agree to participate in this research with the 
express understanding that I may withdraw at any time without bias. I agree that the 






Please contact me/ my receptionist on (phone/ email) 
______________________________ to organise a suitable date and time for the phone 
interview. 
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